The	O
Epstein-Barr	B-protein
virus	I-protein
Rta	I-protein
protein	I-protein
activates	O
lytic	B-DNA
cycle	I-DNA
genes	I-DNA
and	O
can	O
disrupt	O
latency	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
.	O

The	O
transition	O
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
from	O
latency	O
into	O
the	O
lytic	O
cycle	O
is	O
associated	O
with	O
the	O
expression	O
of	O
two	O
immediate-early	B-DNA
viral	I-DNA
genes	I-DNA
,	O
BZLF1	B-DNA
and	O
BRLF1	B-DNA
.	O

Overexpression	O
of	O
ZEBRA	O
,	O
the	O
product	O
of	O
BZLF1	B-DNA
,	O
is	O
sufficient	O
to	O
disrupt	O
latency	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
and	O
epithelial	B-cell_type
cells	I-cell_type
by	O
stimulating	O
expression	O
of	O
lytic	B-DNA
cycle	I-DNA
genes	I-DNA
,	O
including	O
BRLF1	B-DNA
.	O

The	O
BRLF1	B-protein
product	I-protein
Rta	I-protein
functions	O
as	O
a	O
transcriptional	O
activator	O
in	O
both	O
B	B-cell_type
lymphocytes	I-cell_type
and	O
epithelial	B-cell_type
cells	I-cell_type
.	O

However	O
,	O
Rta	B-protein
has	O
recently	O
been	O
reported	O
to	O
disrupt	O
latency	O
in	O
an	O
epithelial	O
specific	O
manner	O
(	O
S.	O
Zalani	O
,	O
E.	O
Holley-Guthrie	O
,	O
and	O
S.	O
Kenney	O
,	O
Proc.	O
Natl.	O
Acad.	O
Sci.	O
USA	O
93	O
:	O
9194-9199	O
,	O
1996	O
)	O
.	O

Here	O
we	O
demonstrate	O
that	O
expression	O
of	O
Rta	B-protein
is	O
also	O
sufficient	O
for	O
disruption	O
of	O
latency	O
in	O
a	O
permissive	B-cell_line
B-cell	I-cell_line
line	I-cell_line
.	O

In	O
HH514-16	B-cell_line
cells	I-cell_line
,	O
transfection	O
of	O
Rta	B-protein
leads	O
to	O
synthesis	O
of	O
ZEBRA	B-protein
,	O
viral	O
DNA	O
replication	O
,	O
and	O
late	O
gene	O
expression	O
.	O

However	O
,	O
Rta	B-protein
by	O
itself	O
is	O
less	O
potent	O
than	O
ZEBRA	B-protein
in	O
the	O
ability	O
to	O
activate	O
most	O
early	O
and	O
late	O
lytic	B-DNA
cycle	I-DNA
genes	I-DNA
.	O

In	O
light	O
of	O
previous	O
work	O
implicating	O
ZEBRA	B-protein
in	O
the	O
activation	O
of	O
Rta	B-protein
,	O
we	O
suggest	O
a	O
cooperative	O
model	O
for	O
EBV	O
entry	O
into	O
the	O
lytic	O
cycle	O
.	O

Expression	O
of	O
either	O
BZLF1	B-DNA
or	O
BRLF1	B-DNA
triggers	O
expression	O
of	O
the	O
other	O
immediate-early	B-protein
factor	I-protein
,	O
and	O
together	O
these	O
activators	O
act	O
individually	O
or	O
in	O
synergy	O
on	O
downstream	B-DNA
targets	I-DNA
to	O
activate	O
the	O
viral	O
lytic	O
cycle	O
.	O

JOURNAL	NULL
OF	NULL
ViroLoGy	NULL
,	NULL
Oct.	NULL
1998	NULL
,	NULL
p.	NULL
7978-7984	NULL
0022-538	NULL
X	NULL
,	NULL
/98/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

72	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Copyright	NULL
©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
Virus	NULL
Rta	NULL
Protein	NULL
Activates	NULL
Lytic	NULL
Cycle	NULL
Genes	NULL
and	NULL
Can	NULL
Disrupt	NULL
Latency	NULL
in	NULL
B	NULL
Lymphocytes	NULL
TOBIAS	NULL
RAGOCZY	NULL
,	NULL
LEE	NULL
HESTON	NULL
,	NULL
anp	NULL
GEORGE	NULL
MILLER*	NULL
Departments	NULL
of	NULL
Molecular	NULL
Biophysics	NULL
and	NULL
Biochemistry	NULL
,	NULL
Pediatrics	NULL
,	NULL
and	NULL
Epidemiology	NULL
and	NULL
Public	NULL
Health	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06520	NULL
Received	NULL
6	NULL
April	NULL
1998/Accepted	NULL
26	NULL
June	NULL
1998	NULL
The	NULL
transition	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
from	NULL
latency	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
two	NULL
immediate-early	NULL
viral	NULL
genes	NULL
,	NULL
BZLF1	NULL
and	NULL
BRLF1L	NULL
.	NULL

Overexpression	NULL
of	NULL
ZEBRA	NULL
,	NULL
the	NULL
product	NULL
of	NULL
BZLF1	NULL
,	NULL
is	NULL
sufficient	NULL
to	NULL
disrupt	NULL
latency	NULL
in	NULL
B	NULL
lymphocytes	NULL
and	NULL
epithelial	NULL
cells	NULL
by	NULL
stimulating	NULL
expression	NULL
of	NULL
lytic	NULL
cycle	NULL
genes	NULL
,	NULL
including	NULL
BRLF1	NULL
.	NULL

The	NULL
BRLF1	NULL
product	NULL
Rta	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
in	NULL
both	NULL
B	NULL
lymphocytes	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
Rta	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
to	NULL
disrupt	NULL
latency	NULL
in	NULL
an	NULL
epithelial	NULL
specific	NULL
manner	NULL
(	NULL
S.	NULL
Zalani	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
,	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9194-9199	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
expression	NULL
of	NULL
Rta	NULL
is	NULL
also	NULL
sufficient	NULL
for	NULL
disruption	NULL
of	NULL
latency	NULL
in	NULL
a	NULL
permissive	NULL
B-cell	NULL
line	NULL
.	NULL

In	NULL
HHS14-16	NULL
cells	NULL
,	NULL
transfection	NULL
of	NULL
Rta	NULL
leads	NULL
to	NULL
synthesis	NULL
of	NULL
ZEBRA	NULL
,	NULL
viral	NULL
DNA	NULL
replication	NULL
,	NULL
and	NULL
late	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
Rta	NULL
by	NULL
itself	NULL
is	NULL
less	NULL
potent	NULL
than	NULL
ZEBRA	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
activate	NULL
most	NULL
early	NULL
and	NULL
late	NULL
lytic	NULL
cycle	NULL
genes	NULL
.	NULL

In	NULL
light	NULL
of	NULL
previous	NULL
work	NULL
implicating	NULL
ZEBRA	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
Rta	NULL
,	NULL
we	NULL
suggest	NULL
a	NULL
cooperative	NULL
model	NULL
for	NULL
EBV	NULL
entry	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

Expression	NULL
of	NULL
either	NULL
BZLF1	NULL
or	NULL
BRLFI1	NULL
triggers	NULL
expression	NULL
of	NULL
the	NULL
other	NULL
immediate-early	NULL
factor	NULL
,	NULL
and	NULL
together	NULL
these	NULL
activators	NULL
act	NULL
individually	NULL
or	NULL
in	NULL
synergy	NULL
on	NULL
downstream	NULL
targets	NULL
to	NULL
activate	NULL
the	NULL
viral	NULL
lytic	NULL
cycle	NULL
.	NULL

Latency	NULL
,	NULL
a	NULL
state	NULL
of	NULL
limited	NULL
viral	NULL
gene	NULL
expression	NULL
observed	NULL
for	NULL
many	NULL
viruses	NULL
,	NULL
is	NULL
a	NULL
prominent	NULL
feature	NULL
of	NULL
infection	NULL
by	NULL
gamma-herpesviruses	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
,	NULL
a	NULL
human	NULL
gammaherpesvirus	NULL
associated	NULL
with	NULL
both	NULL
lymphoid	NULL
and	NULL
epithelial	NULL
cell-derived	NULL
human	NULL
cancers	NULL
,	NULL
is	NULL
latent	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
(	NULL
for	NULL
a	NULL
review	NULL
see	NULL
reference	NULL
28	NULL
)	NULL
.	NULL

EBV	NULL
can	NULL
reactivate	NULL
from	NULL
B-lym-phoid	NULL
cells	NULL
in	NULL
vivo	NULL
,	NULL
an	NULL
event	NULL
that	NULL
can	NULL
be	NULL
simulated	NULL
in	NULL
B-lym-phoid	NULL
cell	NULL
culture	NULL
by	NULL
addition	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
inducing	NULL
agents	NULL
that	NULL
include	NULL
phorbol	NULL
esters	NULL
,	NULL
»	NULL
-butyrate	NULL
,	NULL
calcium	NULL
ionophores	NULL
,	NULL
and	NULL
cross-linking	NULL
of	NULL
surface	NULL
immunoglobulin	NULL
(	NULL
3	NULL
,	NULL
32	NULL
,	NULL
34	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
switch	NULL
between	NULL
latency	NULL
and	NULL
lytic	NULL
cycle	NULL
gene	NULL
expression	NULL
by	NULL
such	NULL
stimuli	NULL
is	NULL
associated	NULL
with	NULL
expression	NULL
of	NULL
two	NULL
immediate-early	NULL
(	NULL
IE	NULL
)	NULL
proteins	NULL
that	NULL
function	NULL
as	NULL
transcriptional	NULL
activators	NULL
,	NULL
ZEBRA	NULL
(	NULL
Z	NULL
EB	NULL
replication	NULL
activator	NULL
)	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
EBV	NULL
BZLF1	NULL
gene	NULL
,	NULL
and	NULL
Rta	NULL
(	NULL
R	NULL
transactivator	NULL
)	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
BRLF1	NULL
gene	NULL
.	NULL

BZLF1	NULL
and	NULL
BRLF1	NULL
are	NULL
expressed	NULL
simultaneously	NULL
,	NULL
usually	NULL
within	NULL
2	NULL
h	NULL
after	NULL
application	NULL
of	NULL
an	NULL
inducing	NULL
stimulus	NULL
(	NULL
34	NULL
,	NULL
37	NULL
,	NULL
50	NULL
,	NULL
52	NULL
)	NULL
.	NULL

ZEBRA	NULL
and	NULL
Rta	NULL
then	NULL
act	NULL
on	NULL
downstream	NULL
promoters	NULL
to	NULL
activate	NULL
a	NULL
cascade	NULL
of	NULL
lytic	NULL
gene	NULL
expression	NULL
,	NULL
including	NULL
in	NULL
some	NULL
permissive	NULL
cell	NULL
backgrounds	NULL
,	NULL
viral	NULL
DNA	NULL
replication	NULL
,	NULL
late	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
the	NULL
assembly	NULL
of	NULL
infectious	NULL
virus	NULL
(	NULL
5	NULL
,	NULL
8	NULL
,	NULL
9	NULL
,	NULL
11	NULL
,	NULL
12	NULL
,	NULL
22	NULL
,	NULL
23	NULL
,	NULL
27	NULL
)	NULL
.	NULL

ZEBRA	NULL
also	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
lytic	NULL
DNA	NULL
replication	NULL
(	NULL
14	NULL
,	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

The	NULL
BRLFI1	NULL
and	NULL
BZLF1	NULL
genes	NULL
are	NULL
expressed	NULL
from	NULL
the	NULL
virus	NULL
in	NULL
an	NULL
overlapping	NULL
transcription	NULL
unit	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
BRLF1	NULL
gene	NULL
is	NULL
expressed	NULL
as	NULL
4.0-	NULL
and	NULL
3.0-kb	NULL
mRNAs	NULL
driven	NULL
from	NULL
its	NULL
upstream	NULL
promoter	NULL
,	NULL
Rp	NULL
;	NULL
the	NULL
two	NULL
mRNAs	NULL
are	NULL
related	NULL
through	NULL
alternative	NULL
splicing	NULL
.	NULL

The	NULL
BZLF1	NULL
gene	NULL
is	NULL
contained	NULL
as	NULL
a	NULL
bicistronic	NULL
unit	NULL
in	NULL
these	NULL
two	NULL
messages	NULL
.	NULL

BZLF1	NULL
is	NULL
also	NULL
expressed	NULL
as	NULL
a	NULL
monocistronic	NULL
1.0-kb	NULL
mRNA	NULL
that	NULL
is	NULL
controlled	NULL
from	NULL
a	NULL
promoter	NULL
immediately	NULL
upstream	NULL
the	NULL
BZLF1	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
ORF	NULL
)	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Molecular	NULL
Biophysics	NULL
and	NULL
Biochemistry	NULL
,	NULL
Yale	NULL
University	NULL
,	NULL
333	NULL
Cedar	NULL
St.	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06510	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
203	NULL
)	NULL
785-4758	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
203	NULL
)	NULL
785-6961	NULL
.	NULL

E-mail	NULL
:	NULL
George_Miller	NULL
@	NULL
gm.yale.edu	NULL
.	NULL

7978	NULL
Zp	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
50	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
ZEBRA	NULL
is	NULL
efficiently	NULL
translated	NULL
from	NULL
the	NULL
bicistronic	NULL
message	NULL
in	NULL
vivo	NULL
(	NULL
30	NULL
)	NULL
.	NULL

A	NULL
key	NULL
unanswered	NULL
question	NULL
that	NULL
is	NULL
addressed	NULL
in	NULL
this	NULL
report	NULL
is	NULL
whether	NULL
ZEBRA	NULL
or	NULL
Rta	NULL
is	NULL
the	NULL
principal	NULL
controlling	NULL
element	NULL
of	NULL
the	NULL
latency	NULL
to	NULL
lytic	NULL
cycle	NULL
switch	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

An	NULL
answer	NULL
to	NULL
this	NULL
question	NULL
is	NULL
important	NULL
to	NULL
the	NULL
basic	NULL
understanding	NULL
of	NULL
the	NULL
mechanisms	NULL
of	NULL
maintenance	NULL
of	NULL
latency	NULL
and	NULL
reactivation	NULL
into	NULL
the	NULL
productive	NULL
cycle	NULL
.	NULL

All	NULL
current	NULL
models	NULL
assume	NULL
that	NULL
latency	NULL
and	NULL
reactivation	NULL
are	NULL
regulated	NULL
through	NULL
cellular	NULL
control	NULL
of	NULL
Zp	NULL
,	NULL
the	NULL
promoter	NULL
that	NULL
regulates	NULL
BZLF1	NULL
,	NULL
and	NULL
Rp	NULL
,	NULL
the	NULL
promoter	NULL
controlling	NULL
BRLF1	NULL
.	NULL

Until	NULL
now	NULL
,	NULL
considerable	NULL
evidence	NULL
has	NULL
favored	NULL
the	NULL
dominant	NULL
role	NULL
of	NULL
ZEBRA	NULL
.	NULL

Transfection	NULL
of	NULL
plasmids	NULL
expressing	NULL
ZEBRA	NULL
into	NULL
B-cell	NULL
lines	NULL
latently	NULL
infected	NULL
with	NULL
EBV	NULL
efficiently	NULL
initiates	NULL
the	NULL
entire	NULL
lytic	NULL
cascade	NULL
leading	NULL
to	NULL
production	NULL
of	NULL
virions	NULL
(	NULL
11	NULL
,	NULL
19	NULL
,	NULL
44	NULL
,	NULL
53	NULL
)	NULL
.	NULL

As	NULL
an	NULL
early	NULL
event	NULL
,	NULL
ZEBRA	NULL
stimulates	NULL
expression	NULL
of	NULL
Rta	NULL
by	NULL
acting	NULL
on	NULL
Rp	NULL
,	NULL
which	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
ZEBRA	NULL
(	NULL
29	NULL
,	NULL
30	NULL
,	NULL
50	NULL
)	NULL
.	NULL

If	NULL
the	NULL
lytic	NULL
cascade	NULL
is	NULL
linear	NULL
,	NULL
with	NULL
ZEBRA	NULL
directing	NULL
synthesis	NULL
of	NULL
Rta	NULL
,	NULL
entry	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
should	NULL
be	NULL
accelerated	NULL
by	NULL
heterologous	NULL
expression	NULL
of	NULL
BRLFI	NULL
.	NULL

Rta	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
that	NULL
drives	NULL
EBV	NULL
gene	NULL
expression	NULL
by	NULL
directly	NULL
binding	NULL
to	NULL
responsive	NULL
promoters	NULL
that	NULL
contain	NULL
Rta	NULL
response	NULL
elements	NULL
;	NULL
Rta	NULL
also	NULL
activates	NULL
other	NULL
promoters	NULL
that	NULL
do	NULL
not	NULL
contain	NULL
identifiable	NULL
Rta	NULL
response	NULL
elements	NULL
,	NULL
presumably	NULL
by	NULL
an	NULL
indirect	NULL
mechanism	NULL
(	NULL
31	NULL
,	NULL
41	NULL
,	NULL
50	NULL
,	NULL
58	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Rta	NULL
is	NULL
known	NULL
to	NULL
synergize	NULL
with	NULL
ZEBRA	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
many	NULL
viral	NULL
genes	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
23	NULL
,	NULL
27	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Available	NULL
evidence	NULL
about	NULL
the	NULL
capacity	NULL
of	NULL
Rta	NULL
to	NULL
activate	NULL
EBV	NULL
lytic	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
conflicting	NULL
(	NULL
4	NULL
,	NULL
12	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Early	NULL
reports	NULL
indicated	NULL
that	NULL
transfection	NULL
of	NULL
Rta	NULL
by	NULL
itself	NULL
could	NULL
not	NULL
disrupt	NULL
latency	NULL
(	NULL
12	NULL
)	NULL
.	NULL

One	NULL
study	NULL
suggested	NULL
that	NULL
Rta	NULL
might	NULL
induce	NULL
low-level	NULL
lytic	NULL
gene	NULL
expression	NULL
in	NULL
lymphoblastoid	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
-derived	NULL
cell	NULL
lines	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
indicated	NULL
that	NULL
Rta	NULL
disrupted	NULL
latency	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
,	NULL
exerting	NULL
a	NULL
positive	NULL
effect	NULL
in	NULL
epithelial	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Several	NULL
observations	NULL
provoked	NULL
us	NULL
to	NULL
reexamine	NULL
the	NULL
role	NULL
of	NULL
EBV	NULL
Rta	NULL
in	NULL
control	NULL
of	NULL
lytic	NULL
cycle	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
Since	NULL
Rta	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
same	NULL
temporal	NULL
class	NULL
as	NULL
ZEBRA	NULL
,	NULL
Rta	NULL
should	NULL
exert	NULL
an	NULL
essential	NULL
regulatory	NULL
function	NULL
during	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

Homologues	NULL
of	NULL
EBV	NULL
Rta	NULL
are	NULL
found	NULL
in	NULL
all	NULL
members	NULL
of	NULL
the	NULL
gammaherpesvirus	NULL
family	NULL
,	NULL
while	NULL
ZEBRA	NULL
is	NULL
often	NULL
poorly	NULL
conserved	NULL
(	NULL
36	NULL
,	NULL
54	NULL
)	NULL
.	NULL

The	NULL
homologue	NULL
of	NULL
EBV	NULL
Rta	NULL
,	NULL
encoded	NULL
in	NULL
ORF	NULL
50	NULL
of	NULL
human	NULL
herpesvirus	NULL
8	NULL
,	NULL
a	NULL
gammaherpesvirus	NULL
associated	NULL
with	NULL
Kaposi	NULL
's	NULL
sarcoma	NULL
and	NULL
primary	NULL
effusion	NULL
lymphoma	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
human	NULL
herpesvirus	NULL
8	NULL
lytic	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
derived	NULL
from	NULL
primary	NULL
effusion	NULL
lymphoma	NULL
(	NULL
51a	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
EBV	NULL
Rta	NULL
can	NULL
likewise	NULL
activate	NULL
lytic	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
at	NULL
37°C	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
8	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

HH514-16	NULL
is	NULL
a	NULL
clonal	NULL
derivative	NULL
of	NULL
the	NULL
P3J-HR-1	NULL
B-cell	NULL
line	NULL
derived	NULL
from	NULL
an	NULL
EBV-positive	NULL
BL	NULL
that	NULL
is	NULL
permissive	NULL
for	NULL
viral	NULL
replication	NULL
(	NULL
43	NULL
)	NULL
;	NULL
Raji	NULL
is	NULL
a	NULL
human	NULL
B-cell	NULL
line	NULL
derived	NULL
from	NULL
a	NULL
BL	NULL
containing	NULL
an	NULL
EBV	NULL
strain	NULL
that	NULL
is	NULL
defective	NULL
for	NULL
DNA	NULL
replication	NULL
and	NULL
late	NULL
gene	NULL
expression	NULL
(	NULL
40	NULL
)	NULL
.	NULL

BJAB	NULL
is	NULL
a	NULL
human	NULL
B-cell	NULL
line	NULL
originating	NULL
from	NULL
an	NULL
EBV-negative	NULL
B-cell	NULL
lymphoma	NULL
(	NULL
35	NULL
)	NULL
;	NULL
BJAB-B1	NULL
is	NULL
the	NULL
same	NULL
cell	NULL
line	NULL
converted	NULL
with	NULL
the	NULL
P3J-HR-1	NULL
EBV	NULL
strain	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Antisera	NULL
.	NULL

Anti-R	NULL
is	NULL
a	NULL
polyclonal	NULL
rabbit	NULL
antiserum	NULL
raised	NULL
to	NULL
a	NULL
purified	NULL
320-amino-acid	NULL
N-terminal	NULL
fragment	NULL
of	NULL
R	NULL
(	NULL
R320	NULL
)	NULL
that	NULL
was	NULL
generated	NULL
by	NULL
using	NULL
the	NULL
pET	NULL
expression	NULL
system	NULL
(	NULL
Novagen	NULL
)	NULL
.	NULL

Anti-ZEBRA	NULL
and	NULL
anti-BLRF2	NULL
are	NULL
polyclonal	NULL
rabbit	NULL
antisera	NULL
raised	NULL
to	NULL
TrpE-BZLF1	NULL
and	NULL
TrpE-BLRF2	NULL
fusion	NULL
proteins	NULL
(	NULL
26	NULL
,	NULL
48	NULL
)	NULL
.	NULL

R3	NULL
is	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
BMRF1	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
SJ	NULL
is	NULL
a	NULL
human	NULL
serum	NULL
with	NULL
reactivity	NULL
to	NULL
EBNA1	NULL
and	NULL
BFRF3	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Chemical	NULL
induction	NULL
.	NULL

Cells	NULL
were	NULL
subcultured	NULL
3	NULL
days	NULL
prior	NULL
to	NULL
drug	NULL
treatment	NULL
or	NULL
transfection	NULL
.	NULL

Drug	NULL
treatment	NULL
consisted	NULL
of	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
10	NULL
ng	NULL
of	NULL
tetra-decanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
per	NULL
ml	NULL
or	NULL
3	NULL
mM	NULL
sodium	NULL
butyrate	NULL
,	NULL
or	NULL
both	NULL
,	NULL
to	NULL
induce	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

Expression	NULL
vectors	NULL
and	NULL
reporter	NULL
plasmids	NULL
.	NULL

The	NULL
ZEBRA	NULL
expression	NULL
vectors	NULL
pBXG1-genomic	NULL
Z	NULL
(	NULL
pBXG1/gZ	NULL
)	NULL
and	NULL
CMV-genomic	NULL
Z	NULL
(	NULL
CMV/gZ	NULL
;	NULL
CMV	NULL
denotes	NULL
cytomegalovirus	NULL
)	NULL
and	NULL
their	NULL
parent	NULL
vectors	NULL
pBXG1	NULL
and	NULL
pHD1013	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
,	NULL
17	NULL
)	NULL
.	NULL

CMV-RIE	NULL
(	NULL
CMV/Rta	NULL
)	NULL
contains	NULL
the	NULL
BRLF1	NULL
gene	NULL
in	NULL
the	NULL
vector	NULL
pHD1013	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
Rta	NULL
expression	NULL
vector	NULL
RTS15	NULL
(	NULL
pRTS/Rta	NULL
)	NULL
,	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Diane	NULL
Hayward	NULL
,	NULL
contains	NULL
the	NULL
BRLF1	NULL
gene	NULL
linked	NULL
to	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
and	NULL
is	NULL
followed	NULL
by	NULL
a	NULL
polyadenylation	NULL
signal	NULL
in	NULL
plasmid	NULL
pRTS2	NULL
.	NULL

RTS15-AHIII	NULL
(	NULL
pRTS	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
excising	NULL
the	NULL
EBV	NULL
BRLF1	NULL
gene	NULL
with	NULL
HindIII	NULL
and	NULL
Xbal	NULL
,	NULL
filling	NULL
in	NULL
the	NULL
sites	NULL
,	NULL
and	NULL
religating	NULL
the	NULL
vector	NULL
.	NULL

The	NULL
chloram-phenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
construct	NULL
ZpCAT	NULL
contains	NULL
the	NULL
BamHI-NeeI	NULL
fragment	NULL
of	NULL
the	NULL
BZLF1	NULL
promoter	NULL
cloned	NULL
into	NULL
pCAT	NULL
basic	NULL
(	NULL
Promega	NULL
)	NULL
;	NULL
RpCAT	NULL
was	NULL
generated	NULL
by	NULL
cloning	NULL
the	NULL
PCR-amplified	NULL
region	NULL
spanning	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
106123	NULL
to	NULL
107143	NULL
(	NULL
1	NULL
)	NULL
of	NULL
the	NULL
BamHI	NULL
R	NULL
fragment	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
into	NULL
the	NULL
Xbal	NULL
site	NULL
in	NULL
pCAT	NULL
basic	NULL
.	NULL

RpATATACAT	NULL
(	NULL
equivalent	NULL
to	NULL
RpCAT	NULL
with	NULL
a	NULL
7-bp	NULL
TATA	NULL
box	NULL
deletion	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
a	NULL
two-step	NULL
PCR	NULL
method	NULL
.	NULL

The	NULL
first	NULL
set	NULL
of	NULL
amplification	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
primers	NULL
5'-GCTCTAGAAAAGG	NULL
CCCTGTCGTCGGG	NULL
(	NULL
1	NULL
)	NULL
and	NULL
5-GCCATTGGCATGGGCG	NULL
(	NULL
I1	NULL
)	NULL
for	NULL
the	NULL
5°	NULL
fragment	NULL
and	NULL
primers	NULL
5'-CCATGCCAATGGCTGACCAGTAATCCATGT	NULL
(	NULL
IN	NULL
)	NULL
and	NULL
(	NULL
IV	NULL
)	NULL
for	NULL
the	NULL
3	NULL
'	NULL
fragment	NULL
.	NULL

The	NULL
second-step	NULL
reaction	NULL
contained	NULL
the	NULL
products	NULL
of	NULL
the	NULL
first	NULL
round	NULL
as	NULL
templates	NULL
and	NULL
primers	NULL
I	NULL
and	NULL
IV	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
pGL2	NULL
basic+	NULL
HMP	NULL
has	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
bacterial	NULL
R320	NULL
expression	NULL
vector	NULL
pET22-R320	NULL
was	NULL
generated	NULL
by	NULL
cloning	NULL
the	NULL
BRLF1	NULL
ORF	NULL
spanning	NULL
residues	NULL
1	NULL
to	NULL
320	NULL
into	NULL
the	NULL
NdeI	NULL
and	NULL
Sall	NULL
sites	NULL
of	NULL
pET22b	NULL
(	NULL
Novagen	NULL
)	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
C-terminal	NULL
His	NULL
tag	NULL
.	NULL

Transfections	NULL
.	NULL

Transfections	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
electroporation	NULL
(	NULL
49	NULL
)	NULL
.	NULL

For	NULL
Western	NULL
analysis	NULL
,	NULL
10	NULL
ag	NULL
of	NULL
plasmid	NULL
DNA	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
plus	NULL
5	NULL
ug	NULL
of	NULL
empty	NULL
vector	NULL
,	NULL
either	NULL
pBXG1	NULL
or	NULL
pRTS	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Reporter	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
CAT	NULL
construct	NULL
plus	NULL
5	NULL
pg	NULL
of	NULL
expression	NULL
vector	NULL
pBXG1	NULL
or	NULL
pRTS	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
pGL2	NULL
basic+	NULL
HMP	NULL
.	NULL

For	NULL
Southern	NULL
analysis	NULL
,	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
per	NULL
transfection	NULL
was	NULL
20	NULL
pg	NULL
(	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
expression	NULL
vector	NULL
or	NULL
one	NULL
expression	NULL
vector	NULL
and	NULL
pHD1013	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
each	NULL
expression	NULL
vector	NULL
.	NULL

Reporter	NULL
assays	NULL
.	NULL

CAT	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
)	NULL
.	NULL

CAT	NULL
results	NULL
represent	NULL
the	NULL
averages	NULL
of	NULL
at	NULL
least	NULL
two	NULL
separate	NULL
transfections	NULL
and	NULL
are	NULL
standardized	NULL
for	NULL
transfection	NULL
efficiency	NULL
with	NULL
luciferase	NULL
.	NULL

Protein	NULL
extracts	NULL
and	NULL
Western	NULL
blots	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
at	NULL
10°	NULL
cells/10	NULL
pl	NULL
.	NULL

Prior	NULL
to	NULL
separation	NULL
on	NULL
SDS-12	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
samples	NULL
(	NULL
20	NULL
wl	NULL
)	NULL
were	NULL
heated	NULL
to	NULL
100°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Following	NULL
electrophoresis	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
by	NULL
electroblotting	NULL
and	NULL
blocked	NULL
in	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
antiserum	NULL
,	NULL
diluted	NULL
in	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
at	NULL
25°C	NULL
for	NULL
2	NULL
h	NULL
,	NULL
then	NULL
washed	NULL
(	NULL
three	NULL
times	NULL
for	NULL
10	NULL
min	NULL
each	NULL
)	NULL
in	NULL
TS	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
200	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
***I-protein	NULL
A	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
washed	NULL
again	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
exposed	NULL
overnight	NULL
with	NULL
intensifying	NULL
screens	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
at	NULL
-70°C	NULL
.	NULL

EBV	NULL
Rta	NULL
DISRUPTS	NULL
LATENCY	NULL
IN	NULL
B	NULL
CELLS	NULL
-	NULL
7979	NULL
A	NULL
3	NULL
N	NULL
S	NULL
a	NULL
aac	NULL
=	NULL
(	NULL
G	NULL
(	NULL
Oe	NULL
0	NULL
=	NULL
%	NULL
xX	NULL
3	NULL
a	NULL
i-3	NULL
c	NULL
co	NULL
O	NULL
O	NULL
E	NULL
[	NULL
est	NULL
kDa	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
-	NULL
112	NULL
EBNA1	NULL
cmu	NULL
nts	NULL
.	NULL

-	NULL
-	NULL
84	NULL
SERUM	NULL
:	NULL
SJ	NULL
Rta	NULL
3	NULL
«	NULL
omar	NULL
cames	NULL
~	NULL
--	NULL
-	NULL
84	NULL
l	NULL
hd	NULL
EAp	NULL
``	NULL
°	NULL
0	NULL
__	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
SERA	NULL
:	NULL
anti-BRLF1	NULL
+	NULL
R3	NULL
B	NULL
8	NULL
o	NULL
-	NULL
2	NULL
+	NULL
g	NULL
a	NULL
3	NULL
$	NULL
o	NULL
g	NULL
$	NULL
€	NULL
p	NULL
y	NULL
€	NULL
&	NULL
£	NULL
of	NULL
$	NULL
f	NULL
f	NULL
f	NULL
f	NULL
5	NULL
F	NULL
m	NULL
ma	NULL
E	NULL
E	NULL
Markers	NULL
1	NULL
2	NULL
3	NULL
40	NULL
5	NULL
6	NULL
7	NULL
kDa	NULL
SERUM	NULL
:	NULL
SJ	NULL
itt	NULL
-	NULL
112	NULL
Rta	NULL
-	NULL
84	NULL
SERUM	NULL
:	NULL
anti-BRLF1	NULL
EA-D	NULL
8	NULL
8	NULL
=s	NULL
.	NULL

SERUM	NULL
:	NULL
R3	NULL
ZEBRA	NULL
E	NULL
_	NULL
ea	NULL
»	NULL
<	NULL
u	NULL
‘	NULL
a	NULL
-	NULL
33	NULL
.	NULL

SERUM	NULL
:	NULL
anti-BZLF1	NULL
common	NULL
LR2	NULL
vite	NULL
-	NULL
19.4	NULL
SERUM	NULL
:	NULL
anti-BLRF2	NULL
FR3	NULL
‘	NULL
ie	NULL
10	NULL
2	NULL
80	NULL
40	NULL
500060	NULL
7	NULL
SERUM	NULL
:	NULL
SJ	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
of	NULL
early	NULL
and	NULL
late	NULL
viral	NULL
genes	NULL
following	NULL
transfection	NULL
of	NULL
BRLF	NULL
]	NULL
into	NULL
B-cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Raji	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
plasmids	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Immunoblots	NULL
prepared	NULL
72	NULL
h	NULL
following	NULL
transfection	NULL
were	NULL
probed	NULL
sequentially	NULL
with	NULL
polyclonal	NULL
rabbit	NULL
antibody	NULL
to	NULL
Rta	NULL
,	NULL
with	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
to	NULL
EA-D	NULL
,	NULL
and	NULL
with	NULL
a	NULL
human	NULL
antibody	NULL
to	NULL
EBNAL	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HH514-16	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
chemically	NULL
induced	NULL
with	NULL
TPA-z-butyrate	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
7	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
,	NULL
the	NULL
cells	NULL
received	NULL
5	NULL
pg	NULL
of	NULL
activator	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
empty	NULL
vector	NULL
.	NULL

In	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
,	NULL
cells	NULL
received	NULL
only	NULL
vector	NULL
pBXG1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
pRTS	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
lane	NULL
7	NULL
,	NULL
both	NULL
BZLF1	NULL
and	NULL
BRLF1	NULL
were	NULL
transfected	NULL
.	NULL

Immunoblots	NULL
were	NULL
probed	NULL
sequentially	NULL
with	NULL
the	NULL
indicated	NULL
antisera	NULL
.	NULL

Anti-BZLF1	NULL
detects	NULL
both	NULL
the	NULL
endogenous	NULL
(	NULL
top	NULL
arrow	NULL
)	NULL
and	NULL
transfected	NULL
(	NULL
bottom	NULL
arrow	NULL
)	NULL
ZEBRA	NULL
.	NULL

ap	NULL
_	NULL
19.4	NULL
7980	NULL
RAGOCZY	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

S	NULL
N	NULL
®	NULL
B3	NULL
i	NULL
5	NULL
+	NULL
ou	NULL
on	NULL
&	NULL
t	NULL
op	NULL
8	NULL
3	NULL
EB	NULL
f	NULL
f	NULL
:	NULL
3	NULL
f	NULL
$	NULL
&	NULL
>	NULL
Eo	NULL
&	NULL
#	NULL
L	NULL
3	NULL
s	NULL
0	NULL
s	NULL
$	NULL
{	NULL
$	NULL
:	NULL
2	NULL
s	NULL
9	NULL
0	NULL
$	NULL
3	NULL
s	NULL
8	NULL
k	NULL
8	NULL
S5	NULL
5	NULL
s	NULL
s	NULL
E	NULL
k	NULL
§	NULL
f	NULL
ww	NULL
mown	NULL
-	NULL
bp	NULL
E	NULL
F	NULL
d.	NULL
«	NULL
--	NULL
»	NULL
*_23130	NULL
q	NULL
®	NULL
-9416	NULL
huts	NULL
-6557	NULL
L	NULL
-4361	NULL
1°	NULL
20	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
Xho	NULL
1.9	NULL
probe	NULL
HH514-16	NULL
Cells	NULL
10	NULL
20	NULL
3	NULL
4	NULL
5006	NULL
oligonucleotide	NULL
probe	NULL
HH514-16	NULL
Cells	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Activation	NULL
of	NULL
EBV	NULL
DNA	NULL
replication	NULL
following	NULL
transfection	NULL
of	NULL
BRLF1	NULL
into	NULL
HH514-16	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
plasmid	NULL
DNA	NULL
containing	NULL
vector	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
vector	NULL
plus	NULL
genomic	NULL
ZEBRA	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
vector	NULL
plus	NULL
Rta	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
both	NULL
activators	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Untreated	NULL
cells	NULL
(	NULL
lane	NULL
5	NULL
and	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
butyrate-treated	NULL
cells	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
and	NULL
positive	NULL
controls	NULL
.	NULL

DNA	NULL
digested	NULL
with	NULL
BamHI	NULL
was	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
using	NULL
either	NULL
the	NULL
Xho	NULL
1.9	NULL
probe	NULL
(	NULL
45	NULL
)	NULL
(	NULL
A	NULL
)	NULL
or	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Episomal	NULL
EBV	NULL
DNA	NULL
(	NULL
E	NULL
)	NULL
and	NULL
input	NULL
vector	NULL
DNA	NULL
(	NULL
€	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

L	NULL
,	NULL
linear	NULL
DNA	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blots	NULL
.	NULL

Samples	NULL
of	NULL
2.5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
harvested	NULL
30	NULL
h	NULL
following	NULL
transfection	NULL
.	NULL

Cellular	NULL
RNA	NULL
prepared	NULL
with	NULL
an	NULL
RNeasy	NULL
Mini	NULL
Kit	NULL
(	NULL
Qiagen	NULL
)	NULL
was	NULL
electrophoresed	NULL
through	NULL
a	NULL
1	NULL
%	NULL
agarose-6	NULL
%	NULL
formaldehyde	NULL
gel	NULL
in	NULL
20	NULL
mM	NULL
MOPS	NULL
(	NULL
morpholinepropanesulfonic	NULL
acid	NULL
[	NULL
pH	NULL
7.0	NULL
]	NULL
)	NULL
,	NULL
the	NULL
RNA	NULL
transferred	NULL
to	NULL
a	NULL
Nytran	NULL
membrane	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
*°P-radiolabeled	NULL
oligonucleotides	NULL
.	NULL

The	NULL
BZLF1	NULL
oligonucleotide	NULL
used	NULL
spanned	NULL
nt	NULL
93	NULL
to	NULL
128	NULL
in	NULL
exon	NULL
I	NULL
of	NULL
the	NULL
BZLF1	NULL
gene	NULL
.	NULL

A	NULL
radiolabeled	NULL
370-bp	NULL
Ncol-PséI	NULL
fragment	NULL
of	NULL
H1	NULL
RNA	NULL
of	NULL
RNase	NULL
P	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
to	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
(	NULL
2	NULL
)	NULL
.	NULL

DNA	NULL
replication	NULL
assay	NULL
.	NULL

Three	NULL
days	NULL
following	NULL
subculturing	NULL
,	NULL
triplicate	NULL
aliquots	NULL
of	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
pooled	NULL
into	NULL
24	NULL
ml	NULL
of	NULL
RPMI	NULL
1640-8	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

After	NULL
a	NULL
3-day	NULL
incubation	NULL
period	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
total	NULL
DNA	NULL
was	NULL
extracted	NULL
(	NULL
49	NULL
)	NULL
.	NULL

After	NULL
resuspension	NULL
in	NULL
TE	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
[	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
5	NULL
wg	NULL
of	NULL
each	NULL
DNA	NULL
sample	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
for	NULL
5	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
fragments	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
0.8	NULL
%	NULL
agarose-1	NULL
X	NULL
Tris-borate-EDTA	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
in	NULL
20	NULL
%	NULL
SSC	NULL
(	NULL
3	NULL
M	NULL
NaCl	NULL
,	NULL
0.3	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-labeled	NULL
1.9-kb	NULL
Xhol	NULL
fragment	NULL
covering	NULL
the	NULL
unique	NULL
sequences	NULL
adjacent	NULL
to	NULL
the	NULL
terminal	NULL
repeat	NULL
region	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
(	NULL
Xho	NULL
1.9	NULL
[	NULL
45	NULL
]	NULL
)	NULL
or	NULL
with	NULL
a	NULL
32-base	NULL
oligonucleotide	NULL
in	NULL
this	NULL
region	NULL
(	NULL
5'-CA	NULL
GCTGTTTITTCGTGGACTTITATACAGTAAGG	NULL
)	NULL
.	NULL

RESULTS	NULL
EBV	NULL
Rta	NULL
activates	NULL
early	NULL
lytic	NULL
gene	NULL
expression	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Zalani	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
transfection	NULL
of	NULL
the	NULL
BRLF1	NULL
gene	NULL
under	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
IE	NULL
promoter	NULL
into	NULL
Raji	NULL
cells	NULL
,	NULL
a	NULL
BL	NULL
B-lymphocyte	NULL
cell	NULL
line	NULL
,	NULL
failed	NULL
to	NULL
activate	NULL
the	NULL
EBV	NULL
lytic	NULL
cycle	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
EBV	NULL
diffuse	NULL
early	NULL
antigen	NULL
(	NULL
EA-D	NULL
)	NULL
,	NULL
a	NULL
lytic	NULL
cycle	NULL
product	NULL
(	NULL
57	NULL
)	NULL
.	NULL

In	NULL
their	NULL
experiments	NULL
,	NULL
however	NULL
,	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

provided	NULL
no	NULL
data	NULL
on	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
Rta	NULL
protein	NULL
.	NULL

To	NULL
monitor	NULL
the	NULL
expression	NULL
of	NULL
Rta	NULL
while	NULL
assessing	NULL
its	NULL
biologic	NULL
activity	NULL
,	NULL
we	NULL
used	NULL
an	NULL
antiserum	NULL
raised	NULL
in	NULL
rabbits	NULL
to	NULL
the	NULL
N-terminal	NULL
320	NULL
amino	NULL
acids	NULL
of	NULL
Rta	NULL
.	NULL

Two	NULL
constructs	NULL
were	NULL
used	NULL
to	NULL
express	NULL
Rta	NULL
in	NULL
Raji	NULL
cells	NULL
One	NULL
,	NULL
under	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
but	NULL
lacking	NULL
mRNA	NULL
3'-end	NULL
processing	NULL
signals	NULL
(	NULL
CMV/Rta	NULL
)	NULL
,	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
construct	NULL
used	NULL
by	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
other	NULL
,	NULL
driven	NULL
by	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
(	NULL
pRTS/Rta	NULL
)	NULL
,	NULL
contained	NULL
signals	NULL
for	NULL
mRNA	NULL
3'-end	NULL
processing	NULL
.	NULL

Transfection	NULL
of	NULL
BZLF1	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
activation	NULL
of	NULL
lytic	NULL
cycle	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
transfection	NULL
of	NULL
BZLF1	NULL
activated	NULL
EA-D	NULL
and	NULL
Rta	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
Rta	NULL
protein	NULL
were	NULL
expressed	NULL
following	NULL
transfection	NULL
of	NULL
pRTS/Rta	NULL
but	NULL
not	NULL
of	NULL
CMV/Rta	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
plasmid	NULL
pRTS/Rta	NULL
also	NULL
activated	NULL
EA-D	NULL
expression	NULL
in	NULL
Raji	NULL
cells	NULL
,	NULL
while	NULL
CMV/Rta	NULL
did	NULL
not	NULL
.	NULL

Since	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
EBNA1	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
samples	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
Rta	NULL
and	NULL
EA-D	NULL
signals	NULL
in	NULL
CMV/Rta-transfected	NULL
cells	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
loading	NULL
artifact	NULL
.	NULL

The	NULL
level	NULL
of	NULL
EA-D	NULL
expressed	NULL
following	NULL
transfection	NULL
of	NULL
pRTS/Rta	NULL
was	NULL
somewhat	NULL
less	NULL
than	NULL
following	NULL
transfection	NULL
of	NULL
BZLF1	NULL
(	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
Zalani	NULL
et	NULL
al	NULL
.	NULL

to	NULL
observe	NULL
lytic	NULL
cycle	NULL
activation	NULL
in	NULL
lymphoid	NULL
cells	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
due	NULL
to	NULL
a	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
EBV	NULL
Rta	NULL
protein	NULL
from	NULL
the	NULL
CMV/Rta	NULL
vector	NULL
.	NULL

In	NULL
related	NULL
experiments	NULL
,	NULL
we	NULL
found	NULL
that	NULL
transfection	NULL
of	NULL
pRTS/	NULL
Rta	NULL
activated	NULL
expression	NULL
of	NULL
mRNAs	NULL
of	NULL
several	NULL
lytic	NULL
cycle	NULL
genes	NULL
,	NULL
including	NULL
BaRF1	NULL
and	NULL
BMRF1	NULL
,	NULL
in	NULL
Raji	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

EBV	NULL
Rta	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
late	NULL
gene	NULL
expression	NULL
and	NULL
lytic	NULL
viral	NULL
DNA	NULL
replication	NULL
in	NULL
permissive	NULL
B	NULL
lymphocytes	NULL
.	NULL

Due	NULL
to	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
EBV	NULL
major	NULL
DNA	NULL
binding	NULL
protein	NULL
,	NULL
Raji	NULL
cells	NULL
are	NULL
not	NULL
permissive	NULL
for	NULL
lytic	NULL
viral	NULL
DNA	NULL
replication	NULL
or	NULL
production	NULL
of	NULL
virions	NULL
.	NULL

However	NULL
,	NULL
in	NULL
cell	NULL
lines	NULL
such	NULL
as	NULL
HH514-16	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
the	NULL
latent	NULL
EBV	NULL
genome	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
inducing	NULL
chemicals	NULL
or	NULL
transfection	NULL
of	NULL
BZLFI1	NULL
to	NULL
high-level	NULL
viral	NULL
lytic	NULL
gene	NULL
expression	NULL
that	NULL
proceeds	NULL
to	NULL
expression	NULL
of	NULL
late	NULL
genes	NULL
and	NULL
production	NULL
of	NULL
progeny	NULL
virus	NULL
.	NULL

Transfection	NULL
of	NULL
pRTS/Rta	NULL
into	NULL
HH514-16	NULL
cells	NULL
led	NULL
not	NULL
only	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
EA-D	NULL
but	NULL
also	NULL
to	NULL
the	NULL
synthesis	NULL
of	NULL
low	NULL
levels	NULL
of	NULL
ZEBRA	NULL
from	NULL
the	NULL
endogenous	NULL
virus	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Endogenous	NULL
ZEBRA	NULL
was	NULL
readily	NULL
distinguished	NULL
from	NULL
ZEBRA	NULL
from	NULL
the	NULL
transfected	NULL
expression	NULL
vector	NULL
due	NULL
to	NULL
a	NULL
convenient	NULL
polymorphism	NULL
within	NULL
BZLF1	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
transfection	NULL
of	NULL
pRTS/Rta	NULL
also	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
21-kDa	NULL
virus	NULL
structural	NULL
protein	NULL
encoded	NULL
in	NULL
BFRF3	NULL
,	NULL
a	NULL
late	NULL
viral	NULL
gene	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
HH514-16	NULL
cells	NULL
with	NULL
comparable	NULL
amounts	NULL
of	NULL
vector	NULL
induced	NULL
neither	NULL
early	NULL
nor	NULL
late	NULL
genes	NULL
.	NULL

As	NULL
in	NULL
Raji	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
transfection	NULL
of	NULL
HH514-16	NULL
cells	NULL
with	NULL
BZLF1	NULL
was	NULL
more	NULL
potent	NULL
than	NULL
transfection	NULL
of	NULL
BRLF1I	NULL
in	NULL
activation	NULL
of	NULL
expression	NULL
of	NULL
EA-D	NULL
;	NULL
BFRF3	NULL
was	NULL
also	NULL
induced	NULL
to	NULL
a	NULL
higher	NULL
level	NULL
by	NULL
ZEBRA	NULL
than	NULL
by	NULL
Rta	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
B95-8	NULL
marmoset	NULL
cells	NULL
,	NULL
another	NULL
line	NULL
that	NULL
is	NULL
completely	NULL
permissive	NULL
for	NULL
EBV	NULL
replication	NULL
,	NULL
transfection	NULL
of	NULL
BRLFI	NULL
also	NULL
induced	NULL
expression	NULL
of	NULL
EA-D	NULL
and	NULL
BFRF3	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
a	NULL
late	NULL
viral	NULL
polypeptide	NULL
in	NULL
HH514-16	NULL
cells	NULL
following	NULL
transfection	NULL
of	NULL
BRLF1	NULL
suggested	NULL
that	NULL
the	NULL
EBV	NULL
genome	NULL
in	NULL
these	NULL
cells	NULL
was	NULL
induced	NULL
into	NULL
lytic	NULL
replication	NULL
.	NULL

Lytic	NULL
EBV	NULL
replication	NULL
is	NULL
accompanied	NULL
by	NULL
amplification	NULL
of	NULL
the	NULL
circular	NULL
EBV	NULL
episome	NULL
and	NULL
a	NULL
complex	NULL
DNA	NULL
processing	NULL
reaction	NULL
that	NULL
generates	NULL
linear	NULL
viral	NULL
genomes	NULL
with	NULL
a	NULL
heterogeneous	NULL
collection	NULL
of	NULL
terminally	NULL
repeated	NULL
DNA	NULL
fragments	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
HH514-16	NULL
cells	NULL
with	NULL
BRLF1	NULL
or	NULL
BZLF1	NULL
led	NULL
to	NULL
amplification	NULL
of	NULL
voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
EBV	NULL
Rta	NULL
DISRUPTS	NULL
LATENCY	NULL
IN	NULL
B	NULL
CELLS	NULL
-	NULL
7981	NULL
Fold	NULL
Activation	NULL
r	NULL
m	NULL
r	NULL
bar	NULL
:	NULL
Libres	NULL
obi	NULL
5D	NULL
50	NULL
B0	NULL
p	NULL
3	NULL
&	NULL
&	NULL
p	NULL
3	NULL
&	NULL
&	NULL
p	NULL
3	NULL
4	NULL
a	NULL
pCAT	NULL
RpATATACAT	NULL
RpCAT	NULL
100	NULL
74	NULL
80	NULL
7	NULL
60	NULL
7	NULL
40	NULL
7	NULL
Relative	NULL
Activity	NULL
20	NULL
7	NULL
cll6	NULL
BJAB-B1	NULL
I	NULL
>	NULL
+oA-~	NULL
ZpCAT	NULL
the	NULL
genome	NULL
and	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
ladder	NULL
of	NULL
terminal	NULL
repeats	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
this	NULL
assay	NULL
also	NULL
detected	NULL
the	NULL
transfected	NULL
plasmids	NULL
;	NULL
however	NULL
,	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
that	NULL
does	NULL
not	NULL
detect	NULL
the	NULL
transfected	NULL
DNA	NULL
also	NULL
demonstrated	NULL
plasmid	NULL
amplification	NULL
and	NULL
terminal	NULL
repeat	NULL
processing	NULL
following	NULL
transfection	NULL
of	NULL
Rta	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Rta	NULL
strongly	NULL
activates	NULL
Rp	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
in	NULL
EBV-positive	NULL
cells	NULL
.	NULL

Since	NULL
Rta	NULL
activates	NULL
ZEBRA	NULL
expression	NULL
and	NULL
ultimately	NULL
the	NULL
entire	NULL
lytic	NULL
viral	NULL
cascade	NULL
in	NULL
HH514-16	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
to	NULL
do	NULL
so	NULL
by	NULL
acting	NULL
on	NULL
one	NULL
or	NULL
both	NULL
promoters	NULL
of	NULL
the	NULL
two	NULL
Relative	NULL
Activity	NULL
BJAB-B1	NULL
ZpCAT	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Comparison	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
CAT	NULL
reporters	NULL
containing	NULL
Rp	NULL
and	NULL
Zp	NULL
by	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autostimulation	NULL
of	NULL
RpCAT	NULL
by	NULL
Rta	NULL
.	NULL

HH514-16	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
16	NULL
pg	NULL
of	NULL
total	NULL
plasmid	NULL
DNA	NULL
with	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
activator	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
luciferase	NULL
re-porter	NULL
.	NULL

CAT	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
72	NULL
h	NULL
following	NULL
transfection	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
standardized	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
using	NULL
the	NULL
luciferase	NULL
data	NULL
.	NULL

Fold	NULL
activation	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
CAT	NULL
activity	NULL
generated	NULL
by	NULL
a	NULL
reporter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Rta	NULL
(	NULL
R	NULL
)	NULL
divided	NULL
by	NULL
the	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
empty	NULL
pRTS	NULL
vector	NULL
(	NULL
U	NULL
)	NULL
.	NULL

The	NULL
data	NULL
for	NULL
RpATATACAT	NULL
are	NULL
standardized	NULL
together	NULL
with	NULL
those	NULL
for	NULL
RpCAT	NULL
,	NULL
where	NULL
RpCAT	NULL
transfected	NULL
with	NULL
empty	NULL
vector	NULL
equals	NULL
1.	NULL
pCAT	NULL
,	NULL
reporter	NULL
lacking	NULL
any	NULL
promoter	NULL
or	NULL
enhancer	NULL
elements	NULL
;	NULL
RpATATACAT	NULL
,	NULL
7-nt	NULL
TATA	NULL
box	NULL
deletion	NULL
in	NULL
Rp	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Effects	NULL
of	NULL
different	NULL
cell	NULL
backgrounds	NULL
on	NULL
transcriptional	NULL
activation	NULL
of	NULL
RpCAT	NULL
and	NULL
ZpCAT	NULL
by	NULL
Rta	NULL
(	NULL
B	NULL
)	NULL
and	NULL
ZEBRA	NULL
(	NULL
C	NULL
)	NULL
.	NULL

For	NULL
both	NULL
panels	NULL
B	NULL
and	NULL
C	NULL
,	NULL
fold	NULL
activation	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
represents	NULL
the	NULL
CAT	NULL
activity	NULL
generated	NULL
by	NULL
the	NULL
reporter	NULL
pCAT	NULL
,	NULL
RpCAT	NULL
,	NULL
or	NULL
ZpCAT	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Rta	NULL
or	NULL
ZEBRA	NULL
divided	NULL
by	NULL
the	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
empty	NULL
vector	NULL
.	NULL

cl16	NULL
,	NULL
HH514-16	NULL
.	NULL

IE	NULL
genes	NULL
,	NULL
namely	NULL
,	NULL
Rp	NULL
and	NULL
Zp	NULL
.	NULL

This	NULL
possibility	NULL
was	NULL
examined	NULL
in	NULL
the	NULL
HHS514-16	NULL
cell	NULL
background	NULL
in	NULL
two	NULL
ways	NULL
:	NULL
by	NULL
the	NULL
use	NULL
of	NULL
reporter-based	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
by	NULL
means	NULL
of	NULL
analysis	NULL
of	NULL
the	NULL
viral	NULL
transcripts	NULL
originating	NULL
from	NULL
Rp	NULL
and	NULL
Zp	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
transient	NULL
assays	NULL
,	NULL
Rta	NULL
stimulated	NULL
its	NULL
own	NULL
promoter	NULL
power-fully	NULL
,	NULL
up	NULL
to	NULL
65-fold	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
RpCAT	NULL
was	NULL
linearly	NULL
related	NULL
to	NULL
the	NULL
input	NULL
dose	NULL
of	NULL
Rta	NULL
expression	NULL
plasmid	NULL
and	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
core	NULL
promoter	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
TATA	NULL
element	NULL
in	NULL
plasmid	NULL
RpATATACAT	NULL
abolished	NULL
any	NULL
Rta-mediated	NULL
activity	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
Rta	NULL
stimulation	NULL
of	NULL
RpCAT	NULL
was	NULL
markedly	NULL
augmented	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
endogenous	NULL
EBV	NULL
genome	NULL
.	NULL

In	NULL
EBV-negative	NULL
BJAB	NULL
cells	NULL
,	NULL
Rta	NULL
activated	NULL
RpCAT	NULL
weakly	NULL
,	NULL
about	NULL
sixfold	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
an	NULL
effect	NULL
of	NULL
cell	NULL
background	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
EBV	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
same	NULL
assays	NULL
with	NULL
BJAB-B1	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
BJAB	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
permanently	NULL
converted	NULL
to	NULL
carriage	NULL
of	NULL
EBV	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
BJAB-B1	NULL
cells	NULL
,	NULL
Rta	NULL
stimulated	NULL
RpCAT	NULL
70-fold	NULL
,	NULL
at	NULL
least	NULL
10-fold	NULL
more	NULL
strongly	NULL
than	NULL
in	NULL
the	NULL
parental	NULL
EBV-negative	NULL
BJAB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
RpCAT	NULL
is	NULL
strongly	NULL
activated	NULL
by	NULL
Rta	NULL
in	NULL
an	NULL
EBV-positive	NULL
cell	NULL
background	NULL
.	NULL

Although	NULL
ZpCAT	NULL
was	NULL
activated	NULL
by	NULL
Rta	NULL
,	NULL
this	NULL
promoter	NULL
was	NULL
7982	NULL
RAGOCZY	NULL
ET	NULL
AL	NULL
.	NULL

Co	NULL
©	NULL
Fa	NULL
2	NULL
a	NULL
E	NULL
sy	NULL
$	NULL
|	NULL
£	NULL
Ale	NULL
Eis	NULL
a	NULL
0	NULL
0	NULL
kb	NULL
SIS	NULL
E	NULL
-	NULL
)	NULL
8B	NULL
#	NULL
#	NULL
-*	NULL
2.3B	NULL
m	NULL
1.35	NULL
-	NULL
i	NULL
V	NULL
.	NULL

Me	NULL
<	NULL
-	NULL
2p	NULL
Probe	NULL
:	NULL
BZLF1	NULL
oligo	NULL
0.24	NULL
82	NULL
)	NULL
6	NULL
Probe	NULL
:	NULL
H1	NULL
RNase	NULL
P	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Activation	NULL
of	NULL
Rp-	NULL
and	NULL
Zp-driven	NULL
transcripts	NULL
from	NULL
the	NULL
latent	NULL
EBV	NULL
genome	NULL
following	NULL
transfection	NULL
of	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
.	NULL

HH514-16	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
chemically	NULL
induced	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
transfected	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
total	NULL
plasmid	NULL
DNA	NULL
(	NULL
5	NULL
pg	NULL
of	NULL
pRTS	NULL
[	NULL
lane	NULL
3	NULL
]	NULL
or	NULL
pRTS/Rta	NULL
[	NULL
lane	NULL
4	NULL
]	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
pBXG1	NULL
[	NULL
lane	NULL
5	NULL
]	NULL
,	NULL
or	NULL
4	NULL
pg	NULL
of	NULL
pBXG1	NULL
plus	NULL
1	NULL
pg	NULL
of	NULL
pBXG1/gZ	NULL
[	NULL
lane	NULL
6	NULL
]	NULL
)	NULL
.	NULL

Total	NULL
cell	NULL
RNA	NULL
prepared	NULL
28	NULL
h	NULL
following	NULL
transfection	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
blotting	NULL
using	NULL
a	NULL
33-nt	NULL
oligonucleotide	NULL
in	NULL
BZLF1	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Transcripts	NULL
initiating	NULL
from	NULL
Rp	NULL
,	NULL
Zp	NULL
,	NULL
and	NULL
vector	NULL
(	NULL
V	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

less	NULL
responsive	NULL
to	NULL
Rta	NULL
than	NULL
was	NULL
RpCAT	NULL
in	NULL
EBV-positive	NULL
cells	NULL
.	NULL

In	NULL
HH514-16	NULL
cells	NULL
,	NULL
Rta	NULL
stimulated	NULL
ZpCAT	NULL
12-fold	NULL
;	NULL
direct	NULL
comparison	NULL
of	NULL
the	NULL
responses	NULL
of	NULL
ZpCAT	NULL
and	NULL
RpCAT	NULL
to	NULL
Rta	NULL
in	NULL
HH514-16	NULL
cells	NULL
revealed	NULL
that	NULL
RpCAT	NULL
was	NULL
about	NULL
sevenfold	NULL
more	NULL
responsive	NULL
than	NULL
ZpCAT	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
BJAB-B1	NULL
cells	NULL
,	NULL
Rta	NULL
did	NULL
not	NULL
stimulate	NULL
ZpCAT	NULL
above	NULL
the	NULL
background	NULL
level	NULL
of	NULL
stimulation	NULL
of	NULL
a	NULL
pCAT	NULL
basic	NULL
vector	NULL
that	NULL
contained	NULL
no	NULL
promoter	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

ZEBRA	NULL
strongly	NULL
activates	NULL
the	NULL
BRLF1	NULL
promoter	NULL
in	NULL
EBV-negative	NULL
cells	NULL
.	NULL

ZEBRA	NULL
behaved	NULL
very	NULL
differently	NULL
from	NULL
Rta	NULL
in	NULL
the	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
to	NULL
Rta	NULL
,	NULL
ZEBRA	NULL
was	NULL
considerably	NULL
more	NULL
active	NULL
in	NULL
an	NULL
EBV-negative	NULL
than	NULL
in	NULL
an	NULL
EBV-positive	NULL
cell	NULL
background	NULL
.	NULL

For	NULL
example	NULL
,	NULL
ZEBRA	NULL
stimulated	NULL
RpCAT	NULL
80-fold	NULL
in	NULL
BJAB	NULL
cells	NULL
and	NULL
only	NULL
4-fold	NULL
in	NULL
BJAB-B1	NULL
cells	NULL
.	NULL

ZEBRA	NULL
stimulated	NULL
ZpCAT	NULL
30-fold	NULL
in	NULL
EBV-negative	NULL
BJAB	NULL
cells	NULL
but	NULL
not	NULL
at	NULL
all	NULL
in	NULL
EBV-positive	NULL
BJAB-B1	NULL
cells	NULL
.	NULL

The	NULL
relatively	NULL
weak	NULL
activity	NULL
of	NULL
ZEBRA	NULL
on	NULL
RpCAT	NULL
and	NULL
ZpCAT	NULL
reporters	NULL
in	NULL
an	NULL
EBV-positive	NULL
background	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
HH514-16	NULL
cells	NULL
,	NULL
where	NULL
RpCAT	NULL
was	NULL
stimulated	NULL
only	NULL
S-fold	NULL
and	NULL
ZpCAT	NULL
was	NULL
not	NULL
stimulated	NULL
at	NULL
all	NULL
.	NULL

The	NULL
differences	NULL
observed	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
in	NULL
the	NULL
three	NULL
different	NULL
cell	NULL
lines	NULL
could	NULL
not	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
differences	NULL
in	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Rta	NULL
was	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
in	NULL
HH514-16	NULL
cells	NULL
,	NULL
where	NULL
it	NULL
was	NULL
highly	NULL
active	NULL
,	NULL
and	NULL
in	NULL
BJAB	NULL
cells	NULL
,	NULL
where	NULL
its	NULL
activity	NULL
was	NULL
low	NULL
.	NULL

ZEBRA	NULL
was	NULL
expressed	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
BJAB	NULL
cells	NULL
,	NULL
where	NULL
it	NULL
was	NULL
highly	NULL
active	NULL
,	NULL
than	NULL
in	NULL
HH514-16	NULL
cells	NULL
,	NULL
where	NULL
its	NULL
activity	NULL
was	NULL
low	NULL
.	NULL

In	NULL
BJAB-B1	NULL
cells	NULL
,	NULL
where	NULL
ZEBRA	NULL
showed	NULL
little	NULL
activity	NULL
,	NULL
its	NULL
expression	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
in	NULL
BJAB	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
transient	NULL
transfection	NULL
assays	NULL
showed	NULL
that	NULL
Rta	NULL
was	NULL
a	NULL
more	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
RpCAT	NULL
and	NULL
ZpCAT	NULL
in	NULL
EBV-containing	NULL
cell	NULL
lines	NULL
than	NULL
was	NULL
ZEBRA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Rta	NULL
activates	NULL
Rp	NULL
and	NULL
Zp	NULL
from	NULL
the	NULL
virus	NULL
.	NULL

A	NULL
probe	NULL
for	NULL
BZLF1	NULL
detects	NULL
the	NULL
4.0-	NULL
and	NULL
3.0-kb	NULL
mRNAs	NULL
originating	NULL
from	NULL
Rp	NULL
and	NULL
the	NULL
1.0-kb	NULL
mRNA	NULL
originating	NULL
from	NULL
Zp	NULL
.	NULL

The	NULL
4.0-kb	NULL
mRNA	NULL
is	NULL
characteristically	NULL
less	NULL
abundant	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
that	NULL
chemical	NULL
induction	NULL
of	NULL
the	NULL
lytic	NULL
cycle	NULL
in	NULL
HH514-16	NULL
cells	NULL
by	NULL
TPA	NULL
and	NULL
n-butyrate	NULL
leads	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
two	NULL
abundant	NULL
3.0-	NULL
and	NULL
1.0-kb	NULL
mRNAs	NULL
detected	NULL
by	NULL
a	NULL
probe	NULL
for	NULL
BZLF1	NULL
;	NULL
this	NULL
finding	NULL
indicates	NULL
that	NULL
both	NULL
Rp	NULL
and	NULL
Zp	NULL
are	NULL
active	NULL
in	NULL
HH514-16	NULL
cells	NULL
.	NULL

Transfection	NULL
of	NULL
ZEBRA	NULL
also	NULL
leads	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
these	NULL
two	NULL
mRNAs	NULL
as	NULL
well	NULL
as	NULL
a	NULL
third	NULL
1.3-kb	NULL
mRNA	NULL
that	NULL
represents	NULL
a	NULL
transcript	NULL
from	NULL
the	NULL
ZEBRA	NULL
expression	NULL
plasmid	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
BRLF1	NULL
also	NULL
leads	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
3.0-	NULL
and	NULL
1.0-kb	NULL
mRNAs	NULL
.	NULL

Thus	NULL
,	NULL
overexpression	NULL
of	NULL
Rta	NULL
following	NULL
transfection	NULL
of	NULL
HH514-16	NULL
cells	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
Rp	NULL
and	NULL
Zp	NULL
,	NULL
the	NULL
two	NULL
promoters	NULL
that	NULL
control	NULL
the	NULL
EBV	NULL
lytic	NULL
cascade	NULL
.	NULL

Zp	NULL
Rp	NULL
<	NULL
4	NULL
<	NULL
BZLFI	NULL
ol6	NULL
}	NULL
®	NULL
®	NULL
BRF	NULL
!	NULL

|	NULL
@	NULL
)	NULL
®	NULL
®	NULL
Latency	NULL
TRE	NULL
ZRE	NULL
ZRE	NULL
<	NULL
-BZLFI	NULL
®	NULL
®	NULL
®	NULL
BRUFL	NULL
®	NULL
®	NULL
®	NULL
Induction	NULL
TRE	NULL
ZRE	NULL
ZRE	NULL
¥s	NULL
<	NULL
1	NULL
E	NULL
<	NULL
1	NULL
BZLF	NULL
]	NULL
$	NULL
®	NULL
BRLFL	NULL
®®	NULL
®	NULL
Autostimulation	NULL
TRE	NULL
ZRE	NULL
ZRE	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Proposed	NULL
model	NULL
for	NULL
disruption	NULL
of	NULL
latency	NULL
in	NULL
HH514-16	NULL
cells	NULL
.	NULL

The	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
BZLF1	NULL
and	NULL
BRLF1	NULL
genes	NULL
are	NULL
illustrated	NULL
.	NULL

See	NULL
Discussion	NULL
for	NULL
an	NULL
explication	NULL
of	NULL
the	NULL
model	NULL
.	NULL

H	NULL
,	NULL
repressive	NULL
host	NULL
factor	NULL
(	NULL
possibly	NULL
histone	NULL
)	NULL
;	NULL
A	NULL
,	NULL
host	NULL
cell	NULL
activator	NULL
;	NULL
ZRE	NULL
,	NULL
ZEBRA	NULL
response	NULL
element	NULL
;	NULL
TRE	NULL
,	NULL
TPA	NULL
response	NULL
element	NULL
,	NULL
also	NULL
known	NULL
as	NULL
ZII	NULL
(	NULL
16	NULL
)	NULL
;	NULL
Z	NULL
,	NULL
ZEBRA	NULL
;	NULL
R	NULL
,	NULL
Rta	NULL
;	NULL
X	NULL
,	NULL
a	NULL
factor	NULL
which	NULL
mediates	NULL
R	NULL
activity	NULL
on	NULL
Rp	NULL
and	NULL
Zp	NULL
.	NULL

voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
DISCUSSION	NULL
Here	NULL
we	NULL
present	NULL
three	NULL
novel	NULL
lines	NULL
of	NULL
evidence	NULL
that	NULL
emphasize	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
EBV	NULL
Rta	NULL
protein	NULL
in	NULL
events	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
viral	NULL
lytic	NULL
cascade	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

First	NULL
,	NULL
transfection	NULL
of	NULL
Rta-expressing	NULL
plasmids	NULL
leads	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
early	NULL
and	NULL
late	NULL
viral	NULL
lytic	NULL
cycle	NULL
polypeptides	NULL
and	NULL
,	NULL
in	NULL
permissive	NULL
B	NULL
cells	NULL
,	NULL
lytic	NULL
viral	NULL
DNA	NULL
replication	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
Rta	NULL
powerfully	NULL
stimulates	NULL
its	NULL
own	NULL
promoter	NULL
,	NULL
Rp	NULL
,	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
EBV	NULL
genome	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
overexpression	NULL
of	NULL
Rta	NULL
in	NULL
permissive	NULL
B	NULL
cells	NULL
leads	NULL
to	NULL
transcription	NULL
from	NULL
Rp	NULL
and	NULL
Zp	NULL
,	NULL
the	NULL
two	NULL
distinct	NULL
promoters	NULL
that	NULL
control	NULL
the	NULL
IE	NULL
genes	NULL
BRLF1	NULL
and	NULL
BZLF1	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Previous	NULL
assumptions	NULL
about	NULL
the	NULL
inability	NULL
of	NULL
Rta	NULL
to	NULL
drive	NULL
lytic	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
lymphoid	NULL
cells	NULL
may	NULL
have	NULL
been	NULL
the	NULL
result	NULL
of	NULL
the	NULL
use	NULL
of	NULL
expression	NULL
vectors	NULL
that	NULL
performed	NULL
unequally	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
and	NULL
yielded	NULL
low	NULL
or	NULL
nondetectable	NULL
levels	NULL
of	NULL
Rta	NULL
protein	NULL
in	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

When	NULL
an	NULL
appropriate	NULL
expression	NULL
system	NULL
was	NULL
used	NULL
,	NULL
transfection	NULL
of	NULL
Rta	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
both	NULL
early	NULL
and	NULL
late	NULL
genes	NULL
.	NULL

In	NULL
HH514-16	NULL
cells	NULL
,	NULL
this	NULL
property	NULL
can	NULL
be	NULL
attributed	NULL
in	NULL
part	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
Rta	NULL
to	NULL
activate	NULL
Zp	NULL
and	NULL
thus	NULL
promote	NULL
ZEBRA	NULL
expression	NULL
from	NULL
the	NULL
endogenous	NULL
virus	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Once	NULL
ZEBRA	NULL
was	NULL
induced	NULL
in	NULL
HH514-16	NULL
cells	NULL
,	NULL
lytic	NULL
DNA	NULL
replication	NULL
and	NULL
progression	NULL
of	NULL
the	NULL
cycle	NULL
to	NULL
late	NULL
gene	NULL
expression	NULL
were	NULL
inevitable	NULL
.	NULL

In	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
such	NULL
as	NULL
Raji	NULL
,	NULL
that	NULL
are	NULL
not	NULL
fully	NULL
permissive	NULL
,	NULL
transfection	NULL
of	NULL
BRLF1	NULL
also	NULL
stimulated	NULL
EA-D	NULL
expression	NULL
and	NULL
several	NULL
other	NULL
lytic	NULL
cycle	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Whether	NULL
examined	NULL
in	NULL
fully	NULL
permissive	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
HH514-16	NULL
,	NULL
or	NULL
in	NULL
Raji	NULL
,	NULL
Rta	NULL
by	NULL
itself	NULL
was	NULL
always	NULL
less	NULL
efficient	NULL
at	NULL
inducing	NULL
lytic	NULL
gene	NULL
expression	NULL
than	NULL
was	NULL
ZEBRA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
maximal	NULL
lytic	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
requires	NULL
the	NULL
joint	NULL
and	NULL
interactive	NULL
contributions	NULL
of	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
.	NULL

In	NULL
reporter-based	NULL
transient	NULL
assays	NULL
Rta	NULL
specifically	NULL
and	NULL
powerfully	NULL
activated	NULL
its	NULL
own	NULL
promoter	NULL
,	NULL
an	NULL
autostimulatory	NULL
activity	NULL
that	NULL
was	NULL
maximal	NULL
in	NULL
EBV-positive	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
EBV	NULL
genome	NULL
could	NULL
contribute	NULL
to	NULL
Rp	NULL
activation	NULL
in	NULL
one	NULL
of	NULL
several	NULL
ways	NULL
.	NULL

Rp	NULL
does	NULL
not	NULL
contain	NULL
known	NULL
binding	NULL
sites	NULL
for	NULL
Rta	NULL
(	NULL
20	NULL
)	NULL
;	NULL
instead	NULL
,	NULL
it	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
cellular	NULL
proteins	NULL
including	NULL
YY1	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
Zif268	NULL
(	NULL
55	NULL
,	NULL
56	NULL
,	NULL
58	NULL
)	NULL
.	NULL

An	NULL
EBV	NULL
gene	NULL
might	NULL
induce	NULL
or	NULL
modify	NULL
one	NULL
or	NULL
more	NULL
cellular	NULL
proteins	NULL
enabling	NULL
it	NULL
to	NULL
bind	NULL
to	NULL
Rp	NULL
by	NULL
an	NULL
indirect	NULL
mechanism	NULL
.	NULL

Alternatively	NULL
,	NULL
a	NULL
latent	NULL
or	NULL
lytic	NULL
EBV	NULL
gene	NULL
product	NULL
that	NULL
is	NULL
induced	NULL
by	NULL
Rta	NULL
may	NULL
mediate	NULL
the	NULL
interaction	NULL
between	NULL
Rta	NULL
and	NULL
Rp	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
proteins	NULL
that	NULL
mediate	NULL
Rta/Rp	NULL
interactions	NULL
remains	NULL
a	NULL
key	NULL
unanswered	NULL
problem	NULL
.	NULL

By	NULL
contrast	NULL
to	NULL
Rta	NULL
,	NULL
ZEBRA	NULL
was	NULL
relatively	NULL
inefficient	NULL
at	NULL
activating	NULL
Rp	NULL
reporter	NULL
constructs	NULL
in	NULL
EBV-positive	NULL
cells	NULL
and	NULL
totally	NULL
inactive	NULL
at	NULL
stimulating	NULL
Zp	NULL
reporters	NULL
in	NULL
this	NULL
background	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
viral	NULL
factors	NULL
or	NULL
virally	NULL
induced	NULL
cellular	NULL
factors	NULL
act	NULL
at	NULL
the	NULL
posttranslational	NULL
level	NULL
to	NULL
repress	NULL
ZEBRA-mediated	NULL
activity	NULL
.	NULL

ZEBRA	NULL
is	NULL
known	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
factors	NULL
that	NULL
could	NULL
provide	NULL
this	NULL
function	NULL
(	NULL
21	NULL
,	NULL
24	NULL
,	NULL
39	NULL
,	NULL
51	NULL
,	NULL
59	NULL
,	NULL
60	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
ZEBRA	NULL
was	NULL
capable	NULL
of	NULL
stimulating	NULL
these	NULL
two	NULL
promoters	NULL
in	NULL
an	NULL
EBV-negative	NULL
background	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
transfection	NULL
of	NULL
ZEBRA	NULL
into	NULL
EBV-positive	NULL
HH514-16	NULL
cells	NULL
led	NULL
to	NULL
appearance	NULL
of	NULL
mRNAs	NULL
initiated	NULL
from	NULL
Rp	NULL
and	NULL
Zp	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
the	NULL
context	NULL
of	NULL
latent	NULL
EBV	NULL
,	NULL
ZEBRA	NULL
may	NULL
not	NULL
autostimulate	NULL
its	NULL
own	NULL
promoter	NULL
directly	NULL
but	NULL
may	NULL
do	NULL
so	NULL
indirectly	NULL
either	NULL
by	NULL
activation	NULL
of	NULL
Rta	NULL
or	NULL
by	NULL
contacting	NULL
the	NULL
Zp	NULL
promoter	NULL
through	NULL
cellular	NULL
factors	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
this	NULL
idea	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
transfection	NULL
of	NULL
ZEBRA	NULL
into	NULL
Raji	NULL
cells	NULL
leads	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
3.0-kb	NULL
bicistronic	NULL
mRNA	NULL
driven	NULL
from	NULL
Rp	NULL
but	NULL
not	NULL
the	NULL
1.0-kb	NULL
monocistronic	NULL
mRNA	NULL
from	NULL
Zp	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

These	NULL
EBV	NULL
Rta	NULL
DISRUPTS	NULL
LATENCY	NULL
IN	NULL
B	NULL
CELLS	NULL
-	NULL
7983	NULL
previous	NULL
studies	NULL
using	NULL
Raji	NULL
cells	NULL
suggested	NULL
that	NULL
ZEBRA	NULL
's	NULL
capacity	NULL
to	NULL
stimulate	NULL
Rp	NULL
,	NULL
rather	NULL
than	NULL
its	NULL
ability	NULL
to	NULL
autostimulate	NULL
Zp	NULL
,	NULL
was	NULL
a	NULL
pivotal	NULL
event	NULL
in	NULL
disruption	NULL
of	NULL
latency	NULL
.	NULL

However	NULL
,	NULL
the	NULL
pathway	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
endogenous	NULL
virus	NULL
following	NULL
transfection	NULL
of	NULL
ZEBRA	NULL
and	NULL
Rta	NULL
appears	NULL
to	NULL
differ	NULL
among	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
present	NULL
experiments	NULL
in	NULL
HH514-16	NULL
cells	NULL
show	NULL
that	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
each	NULL
stimulate	NULL
both	NULL
Zp	NULL
and	NULL
Rp	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
experiments	NULL
do	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
conclude	NULL
whether	NULL
each	NULL
overexpressed	NULL
protein	NULL
stimulates	NULL
both	NULL
promoters	NULL
,	NULL
its	NULL
own	NULL
promoter	NULL
,	NULL
or	NULL
the	NULL
promoter	NULL
of	NULL
its	NULL
partner	NULL
IE	NULL
gene	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
experiments	NULL
clearly	NULL
demonstrate	NULL
that	NULL
in	NULL
permissive	NULL
cells	NULL
,	NULL
both	NULL
Zp	NULL
and	NULL
Rp	NULL
become	NULL
active	NULL
as	NULL
the	NULL
result	NULL
of	NULL
transfection	NULL
of	NULL
either	NULL
IE	NULL
gene	NULL
and	NULL
suggest	NULL
a	NULL
mutual	NULL
cross-stimulatory	NULL
mechanism	NULL
.	NULL

The	NULL
experiments	NULL
lead	NULL
to	NULL
the	NULL
model	NULL
proposed	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
which	NULL
should	NULL
be	NULL
valid	NULL
for	NULL
permissive	NULL
cells	NULL
such	NULL
as	NULL
HH514-16	NULL
.	NULL

During	NULL
latency	NULL
,	NULL
both	NULL
Rp	NULL
and	NULL
Zp	NULL
are	NULL
tightly	NULL
repressed	NULL
by	NULL
cellular	NULL
fac-tors	NULL
,	NULL
by	NULL
higher-order	NULL
chromatin	NULL
structure	NULL
,	NULL
and/or	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
specific	NULL
activators	NULL
.	NULL

Following	NULL
an	NULL
inducing	NULL
stimulus	NULL
,	NULL
some	NULL
cellular	NULL
factors	NULL
or	NULL
structures	NULL
are	NULL
displaced	NULL
or	NULL
modified	NULL
by	NULL
newly	NULL
synthesized	NULL
or	NULL
modified	NULL
cellular	NULL
activators	NULL
.	NULL

On	NULL
Zp	NULL
,	NULL
these	NULL
may	NULL
include	NULL
AP-1	NULL
family	NULL
members	NULL
as	NULL
well	NULL
as	NULL
other	NULL
,	NULL
unidentified	NULL
proteins	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

On	NULL
Rp	NULL
,	NULL
Zif268	NULL
,	NULL
Spl	NULL
,	NULL
or	NULL
other	NULL
proteins	NULL
may	NULL
be	NULL
involved	NULL
(	NULL
56	NULL
,	NULL
58	NULL
)	NULL
.	NULL

During	NULL
an	NULL
amplification	NULL
or	NULL
autostimulation	NULL
event	NULL
,	NULL
Rta	NULL
and	NULL
ZEBRA	NULL
activate	NULL
each	NULL
other	NULL
's	NULL
promoter	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
proteins	NULL
may	NULL
also	NULL
stimulate	NULL
its	NULL
own	NULL
promoter	NULL
;	NULL
however	NULL
,	NULL
this	NULL
capacity	NULL
may	NULL
be	NULL
cell	NULL
specific	NULL
since	NULL
in	NULL
Raji	NULL
cells	NULL
Zp	NULL
is	NULL
not	NULL
activated	NULL
by	NULL
ZEBRA	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

In	NULL
permissive	NULL
cells	NULL
,	NULL
Rta	NULL
activates	NULL
both	NULL
Rp	NULL
and	NULL
Zp	NULL
in	NULL
conjunction	NULL
with	NULL
an	NULL
unidentified	NULL
protein	NULL
whose	NULL
activity	NULL
is	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
EBV	NULL
genome	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
CA12055	NULL
,	NULL
CA16038	NULL
,	NULL
and	NULL
CA20036	NULL
from	NULL
the	NULL
NIH	NULL
to	NULL
G.M	NULL
.	NULL

We	NULL
thank	NULL
T.	NULL
Serio	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
plasmid	NULL
pRTS15	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baer	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
T.	NULL
Bankier	NULL
,	NULL
M.	NULL
D.	NULL
Biggin	NULL
,	NULL
P.	NULL
L.	NULL
Deininger	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
T.	NULL
J.	NULL
Gibson	NULL
,	NULL
G.	NULL
Hatful	NULL
,	NULL
G.	NULL
S.	NULL
Hudson	NULL
,	NULL
S.	NULL
C.	NULL
Satchwell	NULL
,	NULL
C.	NULL
Seguin	NULL
,	NULL
P.	NULL
S.	NULL
Tuffnell	NULL
,	NULL
and	NULL
B.	NULL
G.	NULL
Barrell	NULL
.	NULL

1984	NULL
.	NULL

DNA	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
B95-8	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
.	NULL

Nature	NULL
310:207-211	NULL
.	NULL

2	NULL
.	NULL

Bartkiewicz	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Gold	NULL
,	NULL
and	NULL
S.	NULL
Altman	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
RNA	NULL
molecule	NULL
that	NULL
copurifies	NULL
with	NULL
RNase	NULL
P	NULL
activity	NULL
from	NULL
HeLa	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:488-499	NULL
.	NULL

3	NULL
.	NULL

Bauer	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Hoefler	NULL
,	NULL
and	NULL
H.	NULL
zur	NULL
Hausen	NULL
.	NULL

1982	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
induction	NULL
by	NULL
a	NULL
serum	NULL
factor	NULL
.	NULL

I	NULL
.	NULL

Induction	NULL
and	NULL
cooperation	NULL
with	NULL
additional	NULL
inducers	NULL
.	NULL

Virology	NULL
121:184-194	NULL
.	NULL

4	NULL
.	NULL

Bogedain	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Alliger	NULL
,	NULL
F.	NULL
Schwarzmann	NULL
,	NULL
M.	NULL
Marschall	NULL
,	NULL
H.	NULL
Wolf	NULL
,	NULL
and	NULL
W.	NULL
Jilg	NULL
.	NULL

1994	NULL
.	NULL

Different	NULL
activation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
immediate-carly	NULL
and	NULL
carly	NULL
genes	NULL
in	NULL
Burkitt	NULL
lymphoma	NULL
cells	NULL
and	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:1200-1203	NULL
.	NULL

5	NULL
.	NULL

Buisson	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
Manet	NULL
,	NULL
M.	NULL
C.	NULL
Trescol-Biemont	NULL
,	NULL
H.	NULL
Gruffat	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
early	NULL
protein	NULL
EB2	NULL
is	NULL
a	NULL
posttranscriptional	NULL
activator	NULL
expressed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
EBV	NULL
transcription	NULL
factors	NULL
EB1	NULL
and	NULL
R.	NULL
J.	NULL
Virol	NULL
.	NULL

63:5276-5284	NULL
.	NULL

6	NULL
.	NULL

Cen	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
L.	NULL
C.	NULL
McKnight	NULL
.	NULL

1994	NULL
.	NULL

EBV-immortalized	NULL
isogenic	NULL
human	NULL
B-cell	NULL
clones	NULL
exhibit	NULL
differences	NULL
in	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
on	NULL
the	NULL
BZLF1	NULL
and	NULL
BRLF1	NULL
promoter	NULL
regions	NULL
among	NULL
latent	NULL
,	NULL
lytic	NULL
and	NULL
TPA-activated	NULL
cell	NULL
lines	NULL
.	NULL

Virus	NULL
Res	NULL
.	NULL

31:89-107	NULL
.	NULL

7	NULL
.	NULL

Chavrier	NULL
,	NULL
P.	NULL
,	NULL
H.	NULL
Gruffat	NULL
,	NULL
A.	NULL
Chevallier-Greco	NULL
,	NULL
M.	NULL
Buisson	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
early	NULL
promoter	NULL
DR	NULL
contains	NULL
a	NULL
cis-acting	NULL
element	NULL
responsive	NULL
to	NULL
the	NULL
EBV	NULL
transactivator	NULL
EB1	NULL
and	NULL
an	NULL
enhancer	NULL
with	NULL
constitutive	NULL
and	NULL
inducible	NULL
activities	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:607-614	NULL
.	NULL

8	NULL
.	NULL

Chevallier-Greco	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
Gruffat	NULL
,	NULL
E.	NULL
Manet	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
DR	NULL
enhancer	NULL
contains	NULL
two	NULL
functionally	NULL
different	NULL
domains	NULL
:	NULL
domain	NULL
A	NULL
is	NULL
constitutive	NULL
and	NULL
cell	NULL
specific	NULL
,	NULL
domain	NULL
B	NULL
is	NULL
transactivated	NULL
by	NULL
the	NULL
EBV	NULL
carly	NULL
protein	NULL
R.	NULL
J.	NULL
Virol	NULL
.	NULL

63:615-623	NULL
.	NULL

9	NULL
.	NULL

Chevallier-Greco	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Manet	NULL
,	NULL
P.	NULL
Chavrier	NULL
,	NULL
C.	NULL
Mosnier	NULL
,	NULL
J.	NULL
Daillie	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1986	NULL
.	NULL

Both	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-encoded	NULL
trans-acting	NULL
fac-tors	NULL
,	NULL
EB1	NULL
and	NULL
EB2	NULL
,	NULL
are	NULL
required	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
an	NULL
EBV	NULL
early	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:3243-3249	NULL
.	NULL

10	NULL
.	NULL

Countryman	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Jenson	NULL
,	NULL
R.	NULL
Seibl	NULL
,	NULL
H.	NULL
Wolf	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1987	NULL
.	NULL

Poly-	NULL
7984	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

RAGOCZY	NULL
ET	NULL
AL	NULL
.	NULL

morphic	NULL
proteins	NULL
encoded	NULL
within	NULL
BZLF1	NULL
of	NULL
defective	NULL
and	NULL
standard	NULL
Epstein-Barr	NULL
viruses	NULL
disrupt	NULL
latency	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3672-3679	NULL
.	NULL

Countryman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
,	NULL
1985	NULL
.	NULL

Activation	NULL
of	NULL
expression	NULL
of	NULL
latent	NULL
Epstein-Barr	NULL
herpesvirus	NULL
after	NULL
gene	NULL
transfer	NULL
with	NULL
a	NULL
small	NULL
cloned	NULL
subfragment	NULL
of	NULL
heterogeneous	NULL
viral	NULL
DNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:4085-4089	NULL
.	NULL

Cox	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
J.	NULL
Leahy	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Hardwick	NULL
.	NULL

1990	NULL
.	NULL

An	NULL
enhancer	NULL
within	NULL
the	NULL
divergent	NULL
promoter	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
responds	NULL
synergistically	NULL
to	NULL
the	NULL
R	NULL
and	NULL
Z	NULL
transactivators	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:313-321	NULL
.	NULL

Davis	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Huang	NULL
.	NULL

1988	NULL
.	NULL

Transfer	NULL
and	NULL
expression	NULL
of	NULL
plasmids	NULL
containing	NULL
human	NULL
cytomegalovirus	NULL
immediate-early	NULL
gene	NULL
1	NULL
promoter-en-hancer	NULL
sequences	NULL
in	NULL
eukaryotic	NULL
and	NULL
prokaryotic	NULL
cells	NULL
.	NULL

Biotechnol	NULL
.	NULL

Appl	NULL
.	NULL

Bio-chem	NULL
.	NULL

10:6-12	NULL
.	NULL

Fixman	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
G.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1995	NULL
.	NULL

Replication	NULL
of	NULL
Epstein-Barr	NULL
Virus	NULL
oriLyt	NULL
:	NULL
lack	NULL
of	NULL
a	NULL
dedicated	NULL
virally	NULL
encoded	NULL
origin-binding	NULL
protein	NULL
and	NULL
dependence	NULL
on	NULL
Zta	NULL
in	NULL
cotransfection	NULL
assays	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:2998-3006	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1990	NULL
.	NULL

Autoregulation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
putative	NULL
lytic	NULL
switch	NULL
gene	NULL
BZLFL	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1227-1232	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
phorbol	NULL
ester	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
putative	NULL
lytic	NULL
switch	NULL
gene	NULL
BZLF1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1217-1226	NULL
.	NULL

Francis	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1997	NULL
.	NULL

Alteration	NULL
of	NULL
a	NULL
single	NULL
serine	NULL
in	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
ZEBRA	NULL
protein	NULL
separates	NULL
its	NULL
functions	NULL
of	NULL
transcriptional	NULL
activation	NULL
and	NULL
disruption	NULL
of	NULL
latency	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:3054-3061	NULL
.	NULL

Fresen	NULL
,	NULL
K.-O	NULL
.	NULL

,	NULL
B.	NULL
Merkt	NULL
,	NULL
G.	NULL
W.	NULL
Bornkamm	NULL
,	NULL
and	NULL
H.	NULL
zur	NULL
Hausen	NULL
.	NULL

1977	NULL
.	NULL

Heterogeneity	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
originating	NULL
from	NULL
P3HR-1	NULL
cells	NULL
.	NULL

I	NULL
.	NULL

Studies	NULL
on	NULL
EBNA	NULL
induction	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
19:317-323	NULL
.	NULL

Grogan	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
J.	NULL
Jenson	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
,	NULL
1987	NULL
.	NULL

Transfection	NULL
of	NULL
a	NULL
rearranged	NULL
viral	NULL
DNA	NULL
fragment	NULL
WZhet	NULL
,	NULL
stably	NULL
converts	NULL
latent	NULL
Epstein-Barr	NULL
virus	NULL
infection	NULL
to	NULL
productive	NULL
infection	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:1332-1336	NULL
.	NULL

Gruffat	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1994	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
DNA-binding	NULL
site	NULL
repertoire	NULL
for	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transcription	NULL
factor	NULL
R.	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:1172-1178	NULL
.	NULL

Gutsch	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
E.	NULL
A.	NULL
Holley-Guthrie	NULL
,	NULL
Q.	NULL
Zhang	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Kenney	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
bZip	NULL
transactivator	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
,	NULL
BZLF1	NULL
,	NULL
functionally	NULL
and	NULL
physically	NULL
interacts	NULL
with	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
B.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1939-1948	NULL
.	NULL

Hardwick	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
P.	NULL
M.	NULL
Liebermann	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
new	NULL
Epstein-Barr	NULL
virus	NULL
transactivator	NULL
,	NULL
R	NULL
,	NULL
induces	NULL
expression	NULL
of	NULL
a	NULL
cytoplasmic	NULL
carly	NULL
antigen	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:2274-2284	NULL
.	NULL

Holley-Guthrie	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
E.	NULL
B.	NULL
Quinlivan	NULL
,	NULL
E.-C.	NULL
Mar	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
BMRF1	NULL
promoter	NULL
for	NULL
early	NULL
antigen	NULL
(	NULL
EA-D	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
EBV	NULL
transactivators	NULL
,	NULL
BRLF1	NULL
and	NULL
BZLF1	NULL
,	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3753-3759	NULL
.	NULL

Hong	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
bZip	NULL
dimerization	NULL
domain	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
(	NULL
Z	NULL
)	NULL
protein	NULL
mediates	NULL
lymphoid-specific	NULL
negative	NULL
regulation	NULL
.	NULL

Virology	NULL
229:36-48.	NULL
.	NULL

Jenson	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1988	NULL
.	NULL

Polymorphisms	NULL
of	NULL
the	NULL
region	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
which	NULL
disrupts	NULL
latency	NULL
.	NULL

Virology	NULL
165:549-564	NULL
.	NULL

Katz	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
R.	NULL
P.	NULL
Baumann	NULL
,	NULL
R.	NULL
Sun	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1992	NULL
.	NULL

Viral	NULL
proteins	NULL
associated	NULL
with	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transactivator	NULL
,	NULL
ZEBRA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:378-382	NULL
.	NULL

Kenney	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
E.-C.	NULL
Mar	NULL
,	NULL
and	NULL
M.	NULL
Smith	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
BMLF1	NULL
promoter	NULL
contains	NULL
an	NULL
enhancer	NULL
element	NULL
that	NULL
is	NULL
responsive	NULL
to	NULL
the	NULL
BZLF1	NULL
and	NULL
BRLF1	NULL
transactivators	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3878-3883	NULL
.	NULL

Kieff	NULL
,	NULL
E.	NULL
1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
replication	NULL
,	NULL
p.	NULL
2343-2396	NULL
.	NULL

In	NULL
B.	NULL
N.	NULL
Fields	NULL
,	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Fields	NULL
virology	NULL
,	NULL
vol	NULL
.	NULL

2	NULL
.	NULL

Lippincott-Raven	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pa.	NULL
Kolman	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1996	NULL
.	NULL

Comparing	NULL
transcriptional	NULL
activation	NULL
and	NULL
autostimulation	NULL
by	NULL
ZEBRA	NULL
and	NULL
ZEBRA/c-Fos	NULL
chimeras	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:1493-1504	NULL
.	NULL

Le	NULL
Roux	NULL
,	NULL
F.	NULL
,	NULL
A	NULL
.	NULL

Sergeant	NULL
,	NULL
and	NULL
L.	NULL
Corbo	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
EB1/Zta	NULL
protein	NULL
provided	NULL
in	NULL
trans	NULL
and	NULL
competent	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
productive	NULL
cycle	NULL
genes	NULL
does	NULL
not	NULL
activate	NULL
the	NULL
BZLFI1	NULL
gene	NULL
in	NULL
the	NULL
EBV	NULL
genome	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

77:501-509	NULL
.	NULL

Lin	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
D.	NULL
Sista	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pagano	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
DNA	NULL
polymerase	NULL
promoter	NULL
by	NULL
the	NULL
BRLF1	NULL
immediate-early	NULL
protein	NULL
is	NULL
mediated	NULL
through	NULL
USF	NULL
and	NULL
E2F	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2545-2555	NULL
.	NULL

Luka	NULL
,	NULL
J.	NULL
,	NULL
B.	NULL
Kallin	NULL
,	NULL
and	NULL
G.	NULL
Klein	NULL
.	NULL

1979	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
cycle	NULL
in	NULL
latently	NULL
infected	NULL
cells	NULL
by	NULL
n-butyrate	NULL
.	NULL

Virology	NULL
94:228-231	NULL
.	NULL

Manet	NULL
,	NULL
E.	NULL
,	NULL
H.	NULL
Gruffat	NULL
,	NULL
M.	NULL
C.	NULL
Trescol-Biemont	NULL
,	NULL
N.	NULL
Moreno	NULL
,	NULL
P.	NULL
Chambard	NULL
,	NULL
J.	NULL
F.	NULL
Giot	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1989	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
bicistronic	NULL
mRNAs	NULL
generated	NULL
by	NULL
facultative	NULL
splicing	NULL
code	NULL
for	NULL
two	NULL
transcriptional	NULL
trans-activa-tors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1819-1826	NULL
.	NULL

Mellinghoff	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Daibata	NULL
,	NULL
R.	NULL
E.	NULL
Humphreys	NULL
,	NULL
C.	NULL
Mulder	NULL
,	NULL
K.	NULL
Takada	NULL
,	NULL
and	NULL
T.	NULL
Sairenji	NULL
.	NULL

1991	NULL
.	NULL

Early	NULL
events	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
expression	NULL
after	NULL
acti-vation	NULL
:	NULL
regulation	NULL
by	NULL
second	NULL
messengers	NULL
of	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

Virology	NULL
185:922-928	NULL
.	NULL

Menezes	NULL
,	NULL
J.	NULL
,	NULL
W.	NULL
Leifbold	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
G.	NULL
Clements	NULL
.	NULL

1975	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-negative	NULL
lymphoblastoid	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
BJA-B	NULL
)	NULL
from	NULL
an	NULL
exceptional	NULL
,	NULL
EBV-genome	NULL
negative	NULL
African	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Biomedicine	NULL
22:276-284	NULL
.	NULL

Nicholas	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
S.	NULL
Coles	NULL
,	NULL
C.	NULL
Newman	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Honess	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

the	NULL
herpesvirus	NULL
saimiri	NULL
(	NULL
HVS	NULL
)	NULL
delayed-early	NULL
110-kilodalton	NULL
promoter	NULL
by	NULL
HVS	NULL
immediate-early	NULL
gene	NULL
products	NULL
and	NULL
a	NULL
homolog	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
R	NULL
frens	NULL
activator	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:2457-2466	NULL
.	NULL

Packham	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Brimmel	NULL
,	NULL
D.	NULL
Cook	NULL
,	NULL
A.	NULL
J.	NULL
Sinclair	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1993	NULL
.	NULL

Strain	NULL
variation	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
immediate-early	NULL
genes	NULL
.	NULL

Virology	NULL
192	NULL
;	NULL
541-550	NULL
.	NULL

Pearson	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
B.	NULL
Vroman	NULL
,	NULL
B	NULL
.	NULL

Chase	NULL
,	NULL
T.	NULL
Scully	NULL
,	NULL
M.	NULL
Hummel	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1983	NULL
.	NULL

Identification	NULL
of	NULL
polypeptide	NULL
components	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
carly	NULL
antigen	NULL
complex	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

47:193-201	NULL
.	NULL

Pfitzner	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Becker	NULL
,	NULL
A.	NULL
Rolke	NULL
,	NULL
and	NULL
R.	NULL
Schule	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
antagonism	NULL
between	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
and	NULL
the	NULL
viral	NULL
transactivator	NULL
BZLF1	NULL
is	NULL
mediated	NULL
by	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:12265-12269	NULL
.	NULL

Pulvertaft	NULL
,	NULL
R.	NULL
J.	NULL
V.	NULL
1964	NULL
.	NULL

Cytology	NULL
of	NULL
Burkitt	NULL
's	NULL
tumor	NULL
(	NULL
African	NULL
lymphoma	NULL
)	NULL
.	NULL

Lancet	NULL
i	NULL
?	NULL

238-240	NULL
.	NULL

Quinlivan	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
E.-C.	NULL
Mar	NULL
,	NULL
M.	NULL
S.	NULL
Smith	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
BRLF1	NULL
immediate-early	NULL
gene	NULL
product	NULL
transactivates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
by	NULL
a	NULL
mechanism	NULL
which	NULL
is	NULL
enhancer	NULL
independent	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1817-1820	NULL
.	NULL

Quinlivan	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
E.	NULL
A.	NULL
Holley-Guthrie	NULL
,	NULL
M.	NULL
Norris	NULL
,	NULL
D.	NULL
Gutsch	NULL
,	NULL
S.	NULL
L.	NULL
Bachen-heimer	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Kenney	NULL
.	NULL

1993	NULL
.	NULL

Direct	NULL
BRLF1	NULL
binding	NULL
is	NULL
required	NULL
for	NULL
cooperative	NULL
BZLFI/BRLF1	NULL
activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
carly	NULL
promoter	NULL
,	NULL
BMRFL	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:1999-2007	NULL
.	NULL

Rabson	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1983	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
rare	NULL
Epstein-Barr	NULL
virus	NULL
variant	NULL
that	NULL
enhances	NULL
carly	NULL
antigen	NULL
expression	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:2762-2766	NULL
.	NULL

Rooney	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
T.	NULL
Ragot	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
spliced	NULL
BZLF1	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
transactivates	NULL
an	NULL
early	NULL
EBV	NULL
promoter	NULL
and	NULL
induces	NULL
the	NULL
virus	NULL
productive	NULL
cycle	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3109-3116	NULL
.	NULL

Sato	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Takimoto	NULL
,	NULL
S.	NULL
Tanaka	NULL
,	NULL
J.	NULL
Tanaka	NULL
,	NULL
and	NULL
N.	NULL
Raab-Traub	NULL
.	NULL

1990	NULL
.	NULL

Concatemeric	NULL
replication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
:	NULL
structure	NULL
of	NULL
the	NULL
termini	NULL
in	NULL
virus-producer	NULL
and	NULL
newly	NULL
transformed	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:5295-5300	NULL
.	NULL

Schepers	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Pich	NULL
,	NULL
and	NULL
W.	NULL
Hammerschmidt	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
transcription	NULL
factor	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
AP-1	NULL
family	NULL
links	NULL
RNA	NULL
transcription	NULL
and	NULL
DNA	NULL
replication	NULL
in	NULL
the	NULL
lytic	NULL
cycle	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3921-3929	NULL
.	NULL

Schepers	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Pich	NULL
,	NULL
J.	NULL
Mankertz	NULL
,	NULL
and	NULL
W.	NULL
Hammerschmidt	NULL
.	NULL

1993.	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
lytic	NULL
origin	NULL
of	NULL
DNA	NULL
replication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:4237-4245	NULL
.	NULL

Serio	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
A.	NULL
Angeloni	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
R.	NULL
Sun	NULL
,	NULL
D.	NULL
Katz	NULL
,	NULL
W.	NULL
Van	NULL
Grunsven	NULL
,	NULL
J.	NULL
Middeldorp	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1996	NULL
.	NULL

Two	NULL
21-kilodalton	NULL
components	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
capsid	NULL
antigen	NULL
complex	NULL
and	NULL
their	NULL
relationship	NULL
to	NULL
ZEBRA-associated	NULL
protein	NULL
p21	NULL
(	NULL
ZAP21	NULL
)	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:8047-8054	NULL
.	NULL

Serio	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1997	NULL
.	NULL

Late	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BcLF1	NULL
and	NULL
BFRF3	NULL
promoters	NULL
does	NULL
not	NULL
require	NULL
DNA	NULL
replication	NULL
in	NULL
cis	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:8726-8734	NULL
.	NULL

Sinclair	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
M.	NULL
Brimmell	NULL
,	NULL
F.	NULL
Shanahan	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1991	NULL
.	NULL

Pathways	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
productive	NULL
cycle	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:2237-2244	NULL
.	NULL

Sista	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
J.	NULL
S.	NULL
Pagano	NULL
,	NULL
W.	NULL
Liao	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1993	NULL
.	NULL

Retinoic	NULL
acid	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
protein	NULL
(	NULL
BZLF1	NULL
)	NULL
that	NULL
mediates	NULL
disruption	NULL
of	NULL
latent	NULL
infection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:3894-3898	NULL
.	NULL

51a.Sun	NULL
,	NULL
R.	NULL
,	NULL
S.-F.	NULL
Lin	NULL
,	NULL
L	NULL
Gradoville	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

A	NULL
viral	NULL
gene	NULL
that	NULL
activates	NULL
52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61.	NULL
lytic	NULL
cycle	NULL
expression	NULL
of	NULL
Kaposi	NULL
's	NULL
sarcoma	NULL
associated	NULL
herpesvirus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Takada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Y	NULL
.	NULL

One	NULL
.	NULL

1989	NULL
.	NULL

Synchronous	NULL
and	NULL
sequential	NULL
activation	NULL
of	NULL
latently	NULL
infected	NULL
Epstein-Barr	NULL
virus	NULL
genomes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:445-449	NULL
.	NULL

Takada	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Shimuzu	NULL
,	NULL
S.	NULL
Sakuma	NULL
,	NULL
and	NULL
A.	NULL
Keating	NULL
.	NULL

1986	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
latent	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
genome	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
EBV	NULL
BamHI	NULL
Z	NULL
DNA	NULL
fragment	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

57:1016-1022.	NULL
van	NULL
Santen	NULL
,	NULL
V.	NULL
L.	NULL
1993	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
bovine	NULL
herpesvirus	NULL
4	NULL
immediate-carly	NULL
RNA	NULL
encoding	NULL
a	NULL
homolog	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
R	NULL
transacti-vator	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:773-784	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Coppage	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
cellular	NULL
YY1	NULL
transcription	NULL
factor	NULL
binds	NULL
a	NULL
cis-acting	NULL
,	NULL
negatively	NULL
regulating	NULL
element	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BRLF1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:3268-3274	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Zif268	NULL
cellular	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
immediate-carly	NULL
BRLF1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:3816-3823	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
viral	NULL
latency	NULL
is	NULL
disrupted	NULL
by	NULL
the	NULL
immediate-carly	NULL
BRLF1	NULL
protein	NULL
through	NULL
a	NULL
cell-specific	NULL
mechanism	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9194-9199	NULL
.	NULL

Zalani	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
A.	NULL
Holley-Guthrie	NULL
,	NULL
D.	NULL
E.	NULL
Gutsch	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Kenney	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
immediate-early	NULL
promoter	NULL
BRLF1	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
the	NULL
cellular	NULL
Sp1	NULL
transcription	NULL
factor	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7282-7292	NULL
.	NULL

Zhang	NULL
,	NULL
Q.	NULL
,	NULL
D.	NULL
Gutsch	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
interaction	NULL
between	NULL
p53	NULL
and	NULL
BZLF1	NULL
:	NULL
implications	NULL
for	NULL
Epstein-Barr	NULL
virus	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1929-1938	NULL
.	NULL

Zhang	NULL
,	NULL
Q.	NULL
,	NULL
Y.	NULL
Hong	NULL
,	NULL
D.	NULL
Dorsky	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
S.	NULL
Zalani	NULL
,	NULL
N.	NULL
A.	NULL
Elshiekh	NULL
,	NULL
A.	NULL
Kiehl	NULL
,	NULL
T.	NULL
Le	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
interactions	NULL
between	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
proteins	NULL
BZLF1	NULL
and	NULL
BMRF1	NULL
:	NULL
effects	NULL
on	NULL
EBV	NULL
transcription	NULL
and	NULL
lytic	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:5131-5142.	NULL
zur	NULL
Hausen	NULL
,	NULL
H.	NULL
,	NULL
F.	NULL
O'Neil	NULL
,	NULL
and	NULL
U.	NULL
Freese	NULL
.	NULL

1978	NULL
.	NULL

Persisting	NULL
oncogenic	NULL
her-pesviruses	NULL
induced	NULL
by	NULL
the	NULL
tumor	NULL
promoter	NULL
TPA	NULL
.	NULL

Nature	NULL
272:373-375	NULL
.	NULL

